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Abstract 
This history of antimicrobials is marked with impressive discoveries, the majority of which 
have their origin in natural products. However in this work, the antimicrobial activity of β-
nitrostyrenes and related compounds of synthetic origin is reviewed and investigated with 
a particular focus on the influence of fluorine functionality. 
Substituents
NO2
H (CH3)  
Various fluorinated β-methyl-β-nitrostyrene compounds were prepared, their minimum 
inhibition concentration in cultures of Gram positive, Gram negative and a fungus 
and their lipophilicity was determined. 
Consequently, 1-fluoro-4-(nitroprop-1-enyl) benzene [12c] was found to have the 
NO2
F
1-fluoro-4-(nitroprop-1-enyl) benzene [12c] 
highest activity against E. coli, whereas more lipophilic compounds were more 
effective against Gram positive bacteria. However compound lipophilicity did not 
correlate with antimicrobial activity, highlighting the importance of the structure of 
the antibiotic activity towards the microorganisms studied. 
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Abbreviations 
2-HEAF  2-hydroxyethylammonium formate 
α Alpha 
A Ampere 
Å Angstrom 
Ar Aromatic ring 
β Beta 
B. subtilis Bacillus subtilis 
BDMI 4-[(E)-2-nitroprop-1-enyl]-1,3-benzodioxole 
13C Carbon-13 NMR 
C. albicans Candida albicans 
°C Degree Celsius 
COSY Correlation spectroscopy 
CFU/mL Colony forming units per mL 
CH3COONH4 Ammonium acetate 
Cu(OTf)2 Copper(II) triflate 
CDCl3 Deuterated Chlorofrom 
CH3OK Potassium methoxide 
CH3ONa Sodium methoxide 
CH3SiSNa Sodium trimethylsilanethiolate 
(CH3)3SiCF3 Trimethyl (trifluoromethyl)silane 
d Doublet 
dd Doublet of doublet 
DAST (diethylamino)sulfur trifluoride 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DBN 1,5-diazabicyclo[5.4.0]nonene-5 
DBU 1,5-diazabicyclo[5.4.0]undec-ene-5 
DEPT 45 Distortionless Enhancement by Polarization Transfer 45° angle 
DEPT 90 Distortionless Enhancement by Polarization Transfer 90° angle 
DEPT 135 Distortionless Enhancement by Polarization Transfer 135° angle 
Deoxo – Fluor® Bis (2-methoxyethyl) amino sulfurtrifluoride 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DPP-4 dipeptidyl peptidase-4 
E E configuration 
E. coli Escherichia coli 
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E. faecalis Enterococcus faecalis 
EI Electron Impact 
ESI Electrospray 
EtOH Ethanol 
g Gram 
gCOSY Correlation spectroscopy with gradient 
GC/MS Gas chromatography coupled to mass spectrometry 
GHz Giga hertz 
hr Hour(s) 
1H Proton-1 NMR 
HMBC Heteronuclear multiple-bond correlation spectroscopy 
HSQC Heteronuclear single-quantum correlation spectroscopy 
HPLC High-performance liquid chromatography 
Hz Hertz 
J Coupling constant 
kbar Kilobar 
K2CO2 Potassium carbonate 
KD Partition coefficients 
KF Potassium fluoride 
KOH Potassium hydroxide 
LDA Lithium diisopropylamide 
m multiplet 
mmol Millimole 
mL Millilitre 
mPTPB Mycobacterium protein tyrosine phosphatase B 
m/z Mass to charge ratio 
M+ Molecular ion 
MgSO4 Magnesium sulfate 
MIC Minimum Inhibitory Concentration 
Mtb Mycobacterium tuberculosis 
Na2CO3 Sodium carbonate 
NaOH Sodium hydroxide 
NK-1 Neurokinin-1 
NMR Nuclear magnetic resonance 
NaOH Sodium hydroxide 
NK-1 Neurokinin-1 
NMR Nuclear magnetic resonance 
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p Pentet 
ppm Parts per million 
P.aeruginosa Pseudomonas aeruginosa 
PTPs Protein tyrosine phosphatases 
q Quartet 
QSAR Quantitative structure-activity relationship 
r2 Coefficient of determination 
R Variable group 
δ Delta 
δH Chemical shifts for proton -1 NMR 
δC Chemical shifts for carbon -13 NMR 
s Singlet 
S. aureus Staphylococcus aureus 
SARS Structure-activity relationships 
SPAR Structure-property-activity-relationship 
t triplet 
t-BuOK Potassium tert-butoxide 
THF Tetrahydrofuran 
μg/mL Microgram per millilitre 
μL Microlitre 
UV Ultra Violet 
V Volt 
Z Z Configuration 
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Chapter 1 
 
1 Introduction 
 
1.1 Resistance of micro-organisms to antibiotics 
1.1.1 Background of antimicrobial agents 
Antibiotics are chemicals secreted by bacteria and fungi, they can also be 
synthetic and unnatural to kill or inhibit competitor microbes in the microenvironment and 
thus are part of microbial self protection1,2. At present, many secondary metabolites of 
bacteria and semi-synthetic antimicrobial agents from natural products have been made 
even though drug resistant strains has necessitated continuing modifications to the 
original antibiotic parent compound. From these natural scaffolds medicinal chemists 
modify structures to create semi-synthetic derivatives with improved properties. Some 
naturally occurring antibiotics (such as cephalosporins and macrolides) have much more 
complex chemical structures compared to the synthetic antibiotics (such as sulfa drugs 
and quinolones). 
The first discovery of a successful anti-infective compound was made by a 
German physician Paul Ehrlich. Ehrlich suggested that to be suitable for therapeutic use, 
a chemical should be selectively toxic, i.e. show greater toxicity to the target 
microorganism than to host cells. In 1904 he discovered that the dye trypan red was 
active against the trypanosome causing African sleeping sickness, and suggested that it 
could be used therapeutically. Later, Ehrlich successfully synthesized the drug, 
arsphenamine (Salvarsan) which was used to treat the protozoal disease. Ehrlich, with a 
Japanese scientist, Sahachiro Hata also found that arsphenamine was active against the 
syphilis spirochete. 
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The progress in finding new antimicrobial agents in the next 20 years was slow 
until the aminoacridine, Proflavine, was introduced in 1934. This drug unfortunately was 
too toxic to be used against bacterial infections and was used as a disinfectant and 
antiseptic.3 
The sulfonamide drugs became the first and the only effective antibacterial agents 
against systemic bacterial infections until the advent of penicillin G4, 5. Gerhard Domagk in 
the 1930s, showed that the red dye sulfonamidochrysoidine, synthesized by Bayer, 
completely protected mice against bacterial infections. Later workers at the Pasteur 
Institute showed that the dye was metabolized by, intestinal micro-organisms to the active 
form, sulfanilamide. Sulfanilamide (Prontosil), commercialised by Bayer, was the first 
sulfonamide and it was quickly followed by sulphonamide drugs and the sulfonamides 
were successfully used to treat streptococcal infections.  
In 1928 Penicillin was accidently discovered by Alexander Fleming1, 5 when he 
noted its inhibitory effect on Staphylococcus aureus. Penicillin was the first natural product 
isolated from the fungus, Penicillium notatum. Howard Florey, Ernst Chain and Norman 
Heatley developed Penicillin as the first antibiotic drug. It was first used therapeutically in 
19416. It is active against Gram positive bacteria and the spirochaetes causing syphilis. 
Howard Florey and his coworkers showed that Penicillin G was more effective in 
controlling staphylococcal, streptococcal and pneumococcal infections and syphilis. 
Unfortunately, clinically significant resistance to Penicillin appeared in 1947, but it is still a 
widely used drug. Many successful semi-synthetic beta-lactam derivatives have been 
developed from this scaffold. Cephalosporin, which also contains a β-lactam ring, was 
isolated from a fungus, Cephalosporium, in 1948. Similarly, many semi-synthetic 
derivatives have been developed from this parent compound.  
The discovery of the first of the aminoglycoside antibiotics, streptomycin, in the 
1940’s, extended the anti-bacterial spectrum to include Gram negative bacteria and the 
tubercle bacillus. More antibiotics were quickly discovered, e.g. the tetracyclines, 
erythromycin and other marolides.  
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Overall semi-synthetic derivatives have been developed e.g. sulfa drugs, 
quinolones, azoles etc, with reference to medicinal chemistry to improve drug scaffolds.  
The fluoroquinolones, are a class of synthetic antibacterial agents first synthesized 
in the early 1960s. Several generations of fluoroquinolones have since been synthesized. 
They interfere with bacterial DNA gyrase, eventually inhibiting nucleic acid synthesis.  
The major classes of antibacterial agents (e.g. β-lactams and tetracyclines group, 
synthetic sulfonamides and fluoroquinolones1, 4) are lead compounds for the synthesis of a 
new generation of drugs with improved stability, pharmacokinetics and spectrum of 
activity7. 
 
Despite the large number of effective antibacterial agents that have been developed, drug 
resistance occurred quickly for all the major classes of anti-infectives, so there is an 
urgent need to develop new classes of antimicrobial compounds with diverse microbial 
targets.  
 
1.1.2 The problems of drug resistance in bacteria 
Antimicrobial drugs play an important role in assisting humans in overcoming infections 
due to pathogenic microorganisms, thus providing successful treatments for microbial 
diseases. The rapidly increasing emergence of microbial strains resistant to existing 
antimicrobial agents is a global problem and a serious limitation on the use of 
antimicrobial chemotherapy and this significant threat particularly is relevant to hospitals. 
Outbreak infections due to methicillin-resistant S. aureus, vancomycin-resistant 
enterococci and multidrug resistant Pseudomonas aeruginosa are increasingly being 
reported worldwide8, 9.  
Antimicrobial drug resistance is the ability that microorganisms gain to resist biological 
attack from anti-infective chemotherapeutic agents4. Antimicrobial agents are used for 
medical and veterinary therapy, as disinfectants, antiseptics, agricultural biocides and 
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food and animal feed additives. The massive amounts of antimicrobial agents being used 
for many industrial purposes are causing the emergence and spread of drug resistance 
and giving rise to a rapidly increasing number of pathogenic strains that are resisting 
treatment with anti-infective agents4, 5, 10.  
 
1.1.3 Mechanisms of drug resistance 
The resistance of bacteria to antibiotics is a natural phenomenon4, 6. In nature 
microorganisms develop mutations or acquire resistance genes to common metabolites 
from other microorganisms in the environment. Resistance genes are readily transmitted 
horizontally between related species, and even between unrelated species, so they can 
spread through microbial habitats, particularly if there is a selection pressure from the 
presence of industrial antibiotics.  
There are a few common mechanisms of drug resistance in bacteria.  
(1) Lowered penetration or permeability of drugs into the cell membrane of pathogens. For 
example Penicillin G is not effective against enteric and related gram negative bacteria as 
it cannot penetrate the outer membrane1, 4, 5.  
(2) Alteration in a drug’s target receptors lowers the binding efficacy of the drug. 
Vancomycin is no longer effective against enterococci because the target for the 
vancomycin terminal D-alanine-D-alanine in enterococcal peptidoglycan has been 
changed to D-alanine-D-lactate.  
(3) Drugs may also be expelled by the pathogen’s plasma membrane translocases. Efflux 
pumps can be specific to one drug as in tetracycline resistance. Multidrug-resistant pumps 
are relatively nonspecific and can pump many different unrelated drugs out of the cell. 
Gram negative bacteria such as E. coli and Pseudomonas aeruginosa contain this type of 
efflux system4, 5, 8.  
(4) Bacteria can secrete enzymes that modify drugs thereby inactivating them1, 4, 5. For 
example, secretion of bacterial beta lactamases which hydrolyze the β-lactam antibiotics 
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(e.g. penicillin, cephalosporin) makes them clinically ineffective5, 10 as the β-lactam ring is 
the key structural component of these antibiotics.  
(5) Bacteria can develop an alternative metabolic/biochemical pathway to make their 
products1, 4, 5 and they take up folic acid from their surroundings, therefore they do not 
need to synthesize folic acid when the pathway to make folic acid is blocked by 
sulfonamide drugs.  
(6) Some antimicrobial agents may not be able to inhibit bacteria if they do not have the 
structure that antimicrobial agents can target. In other words, the bacteria are naturally 
resistant to some antimicrobial agents. Mycoplasmas bacteria are naturally resistant to 
penicillins because they do not have a cell wall. 
 
1.1.4 The necessity for new antimicrobial agents 
The number of new anti-infective drugs brought to market in the last 20 years has been 
very low11, 12. No new major class antibiotics since the fluoroquinolones have been 
discovered between 1962 and 20001. The newest naturally occurring antibiotics which 
have been put into clinical practice were the oxazolidinones in 20001. All the other new 
agents have narrow spectrum of activity effective only against a few pathogens or of only 
one type. Another reason is that the development of new antibacterial agents is a costly 
and time-consuming process before a new drug can be brought to market. For this reason 
many pharmaceutical companies have stopped or limited their efforts to develop new 
antimicrobial agents. Only a few pharmaceutical companies are currently active in this 
field10. Scientists have already discovered some major antibiotic cellular targets for drugs 
to kill or inhibit the growth of microorganisms. Those major cellular targets include: the 
bacterial cell wall; the bacterial plasma membrane; synthesis of bacterial proteins, 
bacterial nucleic acids and bacterial metabolism.1 
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Barker has reviewed recent antibacterial drug discovery and structure-based design for 
the development of new antibacterial compounds2. It has been proposed that structure-
based design is an excellent tool for designing compounds with increased potency and 
selectivity. As well as this, a molecular approach can focus chemistry on regions suitable 
for modification, improving stability or bulk properties such as solubility, without affecting 
potency. Barker,2 Bush et al.13 and Projan and Bradford14 have suggested that new drug 
development should focus on some new targets for inhibition such as fatty acid synthesis. 
There is evidence that protein tyrosine phosphatase could be a possible cellular target7, 15.  
 
1.1.5 Protein tyrosine phosphatase 
Protein tyrosine phosphatases (PTPs) exist in both eukaryotic and prokaryotic 
cells. Scientists have investigated the role of protein tyrosine phosphatase in eukaryotes 
and have found that many important cell functions such as, cell growth and differentiation, 
cell motility, metabolism and the immune system. However the discovery of Protein 
tyrosine phosphatases in bacteria occurred much later, the tyrosine phosphorylation in 
bacteria is less common and less well investigated. Zhou et al.15 recently investigated 
protein tyrosine phosphatase B in Mycobacterium tuberculosis (Mtb). They suggested that 
mycobacterium protein tyrosine phosphatase B (mPTPB) secreted by Mtb might mediate 
Mtb survival in marcophages in the host cell. Thus specific mPTPB inhibitors may help the 
host cell to enlarge the intrinsic host signaling pathways to eliminate the tuberculosis 
infection. 
  White7 tested the ability of 4-[(E)-2-nitroprop-1-enyl]-1,3-benzodioxole (Compound 
7) to inhibit human and bacterial tyrosine phosphatases by enzymic assay. She stated 
that nitroalkene compounds related to 7 have been shown to be a competitive, slow and 
reversible inhibitor of protein tyrosine phosphatase. It was found that 7 showed less 
inhibitive ability to protein tyrosine phosphatase, which was consistent with the results 
reported by Park and Pei16 for related benzyl nitropropene compounds. Both of these 
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results have suggested that 7 is a less potent inhibitor of tyrosine phosphatases. Thus, 
White suggested 7 as a potential lead compound to develop anti-infective agents based 
on PTP inhibition. In other words, the nitroalkenes like nitrostyrene and β-methyl-β-
nitrostyrene which have similar chemical structure to 7 are potential compounds for the 
development of new inhibitors of protein tyrosine phosphatase in bacteria. 
 
1.2 Antimicrobial history of nitrostyrene 
1.2.1 Early reports of the antibacterial activity of β-nitrostyrene 
Substituted β-nitrostyrenes [structure 1a] are members of the class of nitroalkenes, and 
their biological activities have been studied previously for a few strains of bacteria or 
fungi17-22.  
NO2
1a
R
 
Reports have shown that β-nitrostyrene [1a] derivatives have a toxic effect on insects23, 24 
and inhibit the growth of fungi20, 23, 25. For example, one of the frequently used fungicides, 
β-bromo-β-nitrostyrene, has a wide-spectrum of activity against fungi26. It may therefore 
be possible to use this type of compound for the protective treatment of organic materials 
such as leather. Based on the biological properties of β-nitrostyrene, it could also be used 
as an antibacterial agent.  
 
Large numbers of derivatives of β-nitrostyrene [1a] were investigated for activity against 
bacteria by Schales and Graefe19. In 1952, they synthesized 55 compounds including 20 
new arylnitroalkenes using the Henry reaction and tested their antibacterial properties 
against the Gram positive bacterium, Micrococcus pyogenes var. aureus, and the Gram 
negative bacterium, Escherichia coli. The β-nitrostyrene derivatives were synthesized 
from benzaldehyde and its derivatives having different substituents on the aromatic ring 
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by reaction with nitromethane using various catalysts. It was shown that, β-nitrostyrene 
derivatives had activity against both the Gram positive and Gram negative bacteria. The 
data showed the effectiveness of selected compounds against both types of bacteria 
especially when substituents such as the methoxy group (-OCH3) were present on the 
aromatic ring19. However, some compounds were less effective than the parent 
compound, β-nitrostyrene. They showed that the effectiveness of each compound against 
M. pyogenes was slightly decreased or not affected (for compound 2) by introducing 
albumin into the culture medium. 
NO2O2N
2  
Early work by Schales and Graefe indicated that the presence of plasma proteins reduced 
the biological activity of antibacterial agents27, but this was not always the case, as they 
showed that addition of albumin to the culture medium actually enhanced the antimicrobial 
activity of compounds 3 and 4.  
 
 
 
 
Additional work done by them showed that chlorine substitutuents at the position 4 (para 
to the vinyl group) (compounds 5 and 6) of the ring showed improved biological activity 
compared with positions 2 and 3 (data not shown).  
 
 
 
Nitroethane was used to form the β-methyl-β-nitrostyrene compounds. The nitropropene 
compounds were found to be more effective against Micrococcus pyogenes var. aureus, 
but were not as effective against E. coli. From the published biological activity of β-
OH
MeO NO2
3
NO2
O2N
4
Cl
Cl
NO2
5
Cl
NO2Cl
6
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nitrostyrene, and other research on nitrostyrene derivatives, it could be concluded that β-
nitrostyrene derivatives have potential as antibacterial agents.  
 
1.2.2 Nitrostyrene derivatives as antimicrobial agents 
Compound [7], is broadly active against a wide range of Gram positive bacteria, Gram 
negative bacteria, filamentous fungi and yeast.28, 29. It is a yellow-colored crystalline 
compound with melting point of 96°C, is insoluble in water but is soluble in organic 
solvents such as acetone and ethanol and is stable at room temperature, and to heat, but 
unstable to UV light on long time exposure. It strongly and reversibly binds to serum 
albumin7.  
NO2O
O
7
 
In 1997, Denisenko et al.28 made a series of known nitrostyrene compounds by the Henry 
reaction in which nitro alkene compounds were synthesized from aromatic aldehydes. 
Denisenko et al. tested these compounds for antimicrobial activity and showed that many 
compounds had biological activity against the bacterial strains. Further studies on 7 by 
White confirmed its broad antimicrobial activity7. She also showed that 7 does not alter the 
function of major bacterial targets such as DNA replication, ribosomal function, cell wall 
synthesis or cell membrane integrity or the synthesis of major fungal targets of cell 
membrane and cell walls. However, 7 did inhibit protein tyrosine phosphatases in bacteria. 
The broad spectrum of activity against resistant bacteria, the metabolic targets of 7 in both 
prokaryotic and eukaryotic microorganisms is sufficiently selective to allow for differential 
toxicity between microbial and mammalian cells7. 
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1.2.3 Recent work on antibacterial activity 
Milhazes et al.22, in 2006, synthesized analogues of β-nitrostyrene and β-methyl-β-
nitrostyrene derivatives with substituents on the aromatic ring such as hydroxy groups (-
OH, compound 8c), methoxy groups (-OCH3, compound 9b) and the methylene dioxy 
group (-OCH2O-, 7) and studied the influence of aromatic substitution patterns on 
antibacterial activity. 
 
 
 
 
They proposed that these substituents would provide different electronic environments, 
possibly affecting the antimicrobial activity of these nitrostyrene derivatives. Milhazes et al. 
also mentioned the development of new antimicrobial drugs generally based on the 
structure-activity relationship (SAR), structure-property-activity relationship (SPAR) and 
quantitative structure-activity relationship (QSAR) studies30, 31. In their investigation of the 
antimicrobial activity, Gram positive bacteria (Staphylococcus aureus and Enterococcus 
faecalis) and Gram negative bacteria (Escherichia coli and Pseudomonas aeruginosa) 
were used to test their nitrostyrene derivatives. It was found that a methyl group on the β-
carbon leads to an increase of the inhibitory effect and the potency was in the range of 2 
to 8 fold greater than the parent compound, β-nitrostyrene. The enhancement of activity 
by the methyl group on the β-carbon was most pronounced on the Gram positive bacteria 
(e.g. S. aureus). The compound 3-hydroxy-4methoxy-β-methyl-β-nitrostyrene [10a] gave 
the best results (MIC 16) against all Gram positive bacteria while the 3,4-dihydroxy-β-
methyl-β-nitrostyrene [8c] was the most effective (MIC 64) against all the Gram negative 
bacteria except for P. aeruginosa. (Table 1) 
HO
MeO
NO2
10a  
 
 
HO
HO
NO2
8c
H3CO
H3CO
NO2
9b
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Table 1: Antimicrobial activity of the β-methyl-β-nitrostyrene derivatives against several 
bacteria22 
Strain 
Minimum Inhibitory Concentration, MIC (mg/L) 
8c 9b 10a 
Escherichia coli 64 256 128 
Pseudomonas aeruginosa 256 256 256 
Enterococcus faecalis 64 32 16 
Staphylococcus aureus 64 32 16 
 
Furthermore, Milhazes et al. found that antibacterial activity did not increase even though 
changing the polarity of the compounds with aromatic substituents would also change the 
electronic characteristics and lipophilicity of the compound (they only tested S. aureus). 
They also concluded that β-methyl-β-nitrostyrene derivatives could be potential anti-
microbial agents for clinical use.  
Recent work related to the synthesis and antimicrobial activity of nitrostyrene derivatives 
was reported by Nicoletti et al.29 They focused mainly on synthesizing β-methyl-β-
nitrostyrene derivatives [11], and evaluated their antimicrobial activity against a panel of 
Gram positive bacteria, Gram negative bacteria and fungi.  
NO2
R
11
R = variable group  
In the nitrostyrene compounds, there were different substituents on the aromatic ring and 
other novel reactions were carried out to produce pyridine, imidazole, benzoxazole, 
thiazole and other analogues. According to their results, most compounds had 
significantly high activity against Gram positive bacteria and fungi. The compound which 
had the highest activity against Gram negative bacteria was the 4-fluoro derivative, 4-(2-
nitroprop-1-enyl)-1-fluorobenzene, 12c.  
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12c
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Based on these discoveries, new designs for the synthesis and development of new 
antibacterial compounds for SAR were continued in this investigation (Masters Program). 
The Henry reaction was used and compounds were prepared under two different 
conditions: Method A and Method B (See Chapter 3). The lipophilicity of each compound 
was measured by determination of octanol-water partition coefficients. The methods of 
evaluation of antibacterial activity were determined by minimum inhibitory concentration 
(MIC). 
 
1.3 Fluorine as a substituent 
This project, in part, investigated the antimicrobial activity of fluorine substituted 
nitrostyrene compounds. The 1906 Nobel Prize in Chemistry was awarded to Henri 
Moissan for his discovery and isolation of the element fluorine. Neil Barrett never received 
the Nobel Prize, however, in 1962 he was the first to produce xenon fluoride thereby 
discovering the reactivity of noble gases in forming fluorides. Organic compounds with 
very stable covalent carbon-fluorine bonds are produced when fluorine atoms or groups 
are substituted for hydrogen or oxygen. An example is the ubiquitous use of Teflon 
(polytetrafluoroethylene) coatings in non-stick frying pans. Two fluorine compounds, 
highlights of medicinal chemistry research in the 1950s, are the anti-inflammatory drug 9α-
fluoro-hydrocortisone acetate and the anticancer drug 5-fluorouracil. In recent times, 
drugs for the treatment of high cholesterol levels include atorvastatin calcium (Lipitor® , 
Pfizer), rosuvastatin calcium (Crestor® , AstraZeneca), ezetimibe (Zetia® , 
Merck/Schering-Plough) and fluvastatin sodium (Lescol® , Novartis), and all contain one 
or more fluorine atoms and are amongst the highest selling prescription drugs developed 
to date. As well as this, compounds with fluorine substitution have been widely used in the 
manufacture of medicines, agrochemicals and polymers in recent years32-35. 
 24 
 
 
 
 
 
 
 
 
 
 
 
Some examples of fluorine-containing drugs 
 
Reports have shown that not more than 40 organofluorine compounds from natural 
products have been isolated, but none of them contained an aryl fluoride in their 
structure36, 37. Previous reviews have shown that the fluorine atom itself is not sterically 
demanding and has a very small van der Waals radius38, which is slightly larger in size to 
the hydrogen atom. Carbon-fluorine bonds are considered the strongest covalent bonds. 
Fluorine always increases hydrogen bond acidity39, and the strength of carbon-fluorine 
bond is high, 439.6 kJ/mol32, 38-40. It can also go to higher bond energy of 485.7 kJ/mol41, 
Table 2 shows some properties of hydrogen, fluorine, chlorine, oxygen and carbon. The 
thermal stability could be enhanced due to this bonding energy. When hydrogen is 
replaced by fluorine, the lipid solubility/lipophilicity or hydrophobicity would be expected to 
increase biological absorption, although this was not the case for the fluorination of 
alkanes39, 42, 43.  
 
 
 
N
O
N O
-
OOH OH
F
Lipitor® 2
Ca
2+
N
N
F
SO
O
O
-
OH OH O
2
Ca
2+
Crestor®
F
N
OH
OH
O
F
Zetia®
N
F
O
ONaOH OH
Lescol®
 25 
Table 2: Some properties of H, F, Cl, O and C 
 
van der Waals 
radius (Å ) 
Electronegativity 
(Pauling) 
Bond Strength with 
carbon (kJ mol-1) 
Hydrogen 1.20 2.1 413 
Fluorine 1.47 4.0 485 
Chlorine 1.75 3.2 339 
Oxygen 1.52 3.4 358 
Carbon 1.70 2.5 346 
 
Fluorine has the highest electronegativity of all the elements, which means it has a high 
ionization potential. Therefore it has a higher ability to withdraw electrons from other 
atoms in molecules towards fluorine, and that modifies the reactivity of compounds 
containing fluorine (refer to Chapter 2). Fluorine has a noteable leaving group ability, 
offering the possibility to design mechanism-based enzyme inhibitors40 and the small 
covalent radius can facilitate docking with drug receptor(s)39. Because of the low F-F bond 
energy (36.6 kcal/mol or 153 kJ/mol), the strong repulsion of its lone pair electrons, when 
reacted with other compounds to form high energy bonds, makes reactions of F2 with 
other elements or compounds extremely exothermic and often explosive44. Other 
concerns are, for example high reactivity, lack of selectivity and potential toxicity (due to 
the inability of fluorinated compounds to be metabolized)33 as well as the risk of free 
radical initiation during reaction. All these properties make working with elemental fluorine 
a challenge44. 
 
1.4 Fluorine in organic chemistry 
Petrik and Cahard45 and other workers indicated that organic compounds of fluorine are 
rare in nature whereas laboratory synthesized fluorinated compounds have readily been 
prepared and research related to fluorine is widespread in chemical sciences. Introduction 
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of fluorine into an organic molecule can be achieved by using nucleophilic fluorine 
reagents (Scheme 1)46, 47 and electrophilic fluorine reagents (Scheme 2)48, 49.  
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Scheme 1: Examples of introduction of fluorine via nucleophilic reagents 
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Scheme 2: Examples of introduction of fluorine aromatic rings via electrophilic reagents 
 
Fluoroorganic chemistry is becoming important in science as it has many applications in 
chemistry and medicinal chemistry. Fluorine-containing compounds are well known 
antibacterial agents; for example, a fluorine atom improves the hydrogen bond donor 
acidity which makes a hydrogen bond with protein and lipid component of biosystem 
easily to elicit bioactivity in bacteria33. In another example Giménez et al.50 showed that a 
fluorine atom improved drug activity due to the increase in hydrophobicity of the drug. 
Ismail51 mentioned that Linezolid can be used totreat infections caused by serious Gram 
positive bacteria and Purser et al.52 gave some examples about recent effective 
fluorinated antibacterial agents now on the market. Moreover, substitution with fluorine in 
nitrostyrene in a previous study53 was shown to enhance the antimicrobial properties of 
these compounds. 
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The van der Waals radius of fluorine is approximately 1.47Å and is between oxygen (1.52 
Å) and hydrogen (1.20 Å)51, 54. It enables fluorine to have the ability to form hydrogen 
bond. The strong C-F bond enables organofluoride compounds to kill pests harmful to 
agriculture. There are examples of organofluorides being used as insecticides [1355 and 
1456], as arthropodicides [15],57 as herbicides [16],58 as fungicides [1759, 1860 and 1961], as 
pesticides [20],62 as agrochemicals [2163 and 2264] and pharmaceuticals [2365, 66 and 2467] 
uses. (Full name of compounds in Appendix) 
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Examples of organofluorides as insecticides, arthropodicides, herbicides, 
fungicides and pesticides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examples of fluorine containing agrochemicals 
 
 
 
 
 
 
Examples of organofluoride pharmaceuticals 
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Other examples of biologically activity fluorine substituted compounds are the important 
phosphodiesterase inhibitors Roflumilast and N-[1-(2-chloro-phenyl)ethyl]-2-(4-fluoro-
phenoxy)benzamide [25]51.  
 
Two examples of phosphodiesterase inhibitors 
 
 
 
 
 
 
Previous discoveries of fluorine-containing compounds that showed effective antimicrobial 
properties are exemplified by the fluoro-quinolones and the fluorinated quinazoline 
derivatives68, 69. Fluoroquinazoline has been widely used as a fungicide70 herbicide71 and 
additionally as an antitumor agent72. Fluoro-quinolones, first approved in the 1960s, had 
emerged as a significant class of chemotherapeuric agents73. Clairefond et al.73 showed 
the effect of fluorine at carbon-5, 6 or 8 in a series of compounds that were tested against 
E. coli DNA-gyrase.  
Fluoro-quinolone compound with C-6 fluorine substitution 
 
 
 
 
 
They found that fluorine substitution at carbon-6 [26] or -8 showed enhancements of 
antimicrobial activity against both Gram positive and Gram negative bacteria. However, 
fluorine substitution at carbon -5 had markedly decreased activity due to compensatory 
electronic effects. Koga et al. carried out similar experiments but obtained markedly 
different results in the potency of the compound substituted at carbon-8 in vitro (10 fold 
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less active).74 The oxazolidinones were other examples given by Barbachyn et al.75 that 
showed fluorine substitution enhanced antibacterial activity. He referred to the structure 
activity-relationships of Gregory et al.76 who postulated that reducing the electron density 
in the phenyl ring of phenyloxazolidinones by substitution of electron withdrawing groups 
in the para position might increase the potency of the compound. Barbachyn et al. 
introduced a stronger electron withdrawing group (e.g. fluorine) in their test compound 27 
to determine its antibacterial activity. Eventually, they proved that fluorine substitutions 
had significantly enhanced the potency better than that with chlorine substitution. 
N O
H
NHAc
R2
R3
R1
O
O
27  
(R1 = alkoxy, amino; R2 = H, F; R3 = F, Cl, CF3) 
 
1.4.1 Introduction of fluorine into heterocyclic and aromatic compounds 
Many reviews have illustrated that special fluorinating reagents are commonly used to 
introduce elemental fluorine into heterocycles (Scheme 3)77-81. Further fluorination of 
heterocycles [compound 28 – 30] can also be carried out by using the Balz-Schiemann 
reaction82 to convert –NH2 to –F, or halogen exchange methods83, or reaction with high-
valency metal fluorides84.  
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Scheme 3: Examples of the introduction of fluorine into heterocycles 
 
Another typical example is that of the fluoroquinolones, which have been mentioned 
previously. Early organometallic fluorinating reagents, because of their limited thermal 
stability, caused the incorporation of fluorine into organic molecules to be less developed 
than in the case of early work with hydrocarbons85. Later, fluorinated organometallic 
reagents were developed with good thermal stability and so more fluorinated 
organometallic compounds were synthesized. An example of the effect of aryl ring 
fluorination on the antimicrobial activities was the compound 12c53 which showed 
significant enhancement of activity on Gram negative bacteria.  
 
1.4.2 Trifluoromethyl substitution in organic compounds 
Bis (2 – methoxyethyl) amino sulfurtrifluoride (Deoxo – Fluor®) discovered by Lal and co-
workers86, 87 is a very versatile fluorinating reagent in organic synthesis serving as a 
thermally stable alternative to (diethylamino)sulfurtrifluoride (DAST) and can transform 
carboxylic acids to acid fluorides or trifluoromethyl derivatives. (Scheme 4) 
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Scheme 4: Trifluoromethylation of carboxylic acids via Deoxo – Fluor® 
 
Trimethyl(trifluoromethyl)silane, (CH3)3SiCF3, (Ruppert – Prakash reagent) is widely used 
for nucleophilic trifluoromethylation. (Scheme 5)88, 89 
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Scheme 5: Nucleophilic trifluoromethylation by means of Ruppert – Prakash reagent 
 
1,3-Dihydro-3,3-dimethyl-1-(trifluoromethyl)-1,2-benzodioxole known as the Togni reagent 
is an electrophilic trifluoromethylation reagent based on hypervalent iodine. (Scheme 6)90 
R
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Scheme 6: Electrophilic trifluoromethylation via Togni reagent 
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The bis aryl thiotrifluoromethyl reagents shown below are also electrophilic 
trifluoromethylating reagents [compound 31, 32].91 
 
 
 
 
Trifluoromethylated aromatics can also be prepared by converting benzotrichloride into 
benzotrifluoride [compound 33] (Scheme 7).92 Hydrogen fluoride could also be used.93  
CCl3 CF3
SbF3, 125
o
C
distil off product
33
58-66% yield 
 
Scheme 7: Conversion of benzotrichloride into benzotrifluoride 
 
The trifluoromethyl group (-CF3) itself has a high electron withdrawing effect similar to that 
of oxygen94 and has a size slightly larger than an isopropyl group39. The effect of 
substitution of –CF3 on organic compounds is to assist the changing of regioselectivity95 
(from an –(S) or –(R) enantiomer transformed into a chiral compound) and reactivity96 (by 
producing different compounds by the same chemical reaction (compared to –CH3) of the 
compounds. McClinton and McClinton97 have commented that –CF3 causes minimal 
disruption to an enzyme substrate complex98 due to only slight effect of the bond length 
when a trifluoromethyl group replaces a methyl group attached to a carbon. As well as 
this, Maier et al.99 and Reynolds et al.100 pointed out the high lipophilicity of -CF3 in 
pharmaceutical and agrochemical compounds. When present showed an improvement in 
membrane transport characteristics in vivo, thereby facilitating lower dosage. Muller101 
suggested lipophilicity is strongly dependent on the position of the fluorine within the 
molecule.  
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The trifluoromethyl containing compound 35 showed at least 3-fold potency of 
inhibition over the non-trifluoro substituted compound [34].102 
 
1.4.3 Trifluoromethoxy substitution in organic compounds 
The trifluoromethoxy group (-OCF3), should impart physical properties consistent with its 
higher electron withdrawing ability and may alter lipophilicity compared with its methoxy 
analogue103. Due to its unusual stability, the -OCF3 group is strongly resistant to strong 
acids, strong bases and strong oxidizing and reducing conditions104, 105. Trifluoromethoxy 
compounds [36] (or trifluoromethyl ethers) can be prepared by reacting a variety of 
substituted phenols with hydrogen fluoride in excess carbon tetrachloride in a closed 
pressure vessel under autogeneous pressure106. (pressure generated from the reaction) 
(Scheme 8) 
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Scheme 8: Conversion of substituted phenol to trifluoromethyl ether derivative 
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The deactivation of the aromatic system occurs when there is substitution of the 
trifluoromethoxy group on an aromatic ring, even though a trifluoromethoxy group could 
exhibit electron withdrawing behavior similar to the halogens107. It has been shown that 
the following substituted trifluoromethoxyphenyl compound [37] has valuable 
pharmacological activity (as a hypoglycemic agent to lower blood glucose level)108. 
 
 
 
 
1.5 The roles of fluorine in medicinal chemistry 
Drugs containing fluorine atoms have constituted around 5 to 15% of the total number of 
drugs on the world market over the past 50 years39. Medicinal chemists will have much 
more success in synthesizing and designing new fluorinated drugs now that new 
fluorinating methodologies and fluorinated commercial intermediates continue to be made 
available. Recent reviews by Kirk44 and Hagmann39 highlighted recent developments of 
fluorine containing drugs.  
 
Some examples of fluorine in medicinal chemistry: 
 
3-(((2S,3S)-2-(3,5-bis(trifluoromethyl)benzyloxy)-3-phenylmorpholino)methyl)-1H-1,2,4-
triazol-5(4H)-one [compound 38]
109
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NK-1 Antagonists, in vivo potency being improved by 
fluorine substitution. Removal of any –CF3 group from the 
compound results in a 3-fold decrease in receptor affinity. This 
drug is for treatment of chemotherapy induced nausea and 
vomiting. Also NK-1 antagonists contain a bis-
trifluoromethylphenyl group would help for central nervous 
system penetration. 
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N-((2S,3S)-4-(4-chlorophenyl)-3-phenylbutan-2-yl)-2-(3,5-difluorophenoxy)-2-
methylpropanamide [compound 39]
110
 
 
 
 
 
 
 
 
 
(R)-3-amino-4-(2,5-difluorophenyl)-1-(3-trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-
α]pyrazin-7(8H)-yl)butan-1-one [compound 40]
111 
 
 
 
 
 
 
 
[(3R)-4-(4-Chlorobenzyl)-7-fluoro-5-acetyl-1,2,3,4-tetrahydrocyclopenta-[ 
b]indol-3-yl]acetic Acid [compound 41]
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Covalent binding of cannabinoid-1 receptor was improved 
by introduction of fluorine atoms. The covalent protein 
binding and bioavailability were 2-fold improved by two 
additional of fluorine atoms on the phenoxy ring. 
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D2 Prostaglandin Receptor Antagonists. Treatment of allergic 
rhinitis, the parent compound containing methylsulfone group 
was replaced by a fluorine atom and improved the biliary 
properties, plasma clearance properties and lengthened the 
plasma half-life of the drug. 
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Enhanced protency of a DPP-4. Treatment for Type 2 
Diabetes, this 2,5-difluorophenyl derivative was almost 5-fold 
more potent than the fluorine free dipeptidyl peptidase-4 
inhibitors (DPP-4). It showed that fluorine substitutions on the 
phenyl ring of triazolopiperazine of DPP-4 played an important 
role in the improvement in potency and pharmacokinetics. 
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Falicalcitral [compound 42]
113
 
 
 
 
 
 
 
 
These successful biochemical outcomes became the lead compounds for later rational 
drug design. 
 
1.6 Significance of the project 
The increasing microbial resistance of clinically important bacteria to current antibiotics is 
of great concern for public health suggesting an increased need for new, more effective 
and safer antibacterial agents. The aim of this project is to develop highly efficient -
nitrostyrene derivatives as antibacterial agents. Previous research on the structure activity 
relationships (SAR) of these compounds for antibacterial activity revealed that a 
substance with a fluorine substituent on the benzene ring showed the highest activity 
against Gram negative bacteria53. Furthermore, the number of new effective antimicrobial 
agents with selective toxicity brought to the market in the past 20 years has been very low. 
It is necessary to synthesize and design more similar or novel compounds based on the 
fluorinated nitrostyrene compound [12c] as well as identifying their antibacterial properties.  
 
 
 
 
 
HO OH
CH2
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CF3
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Falicalcitral an example of increased metabolic stability by 
fluorine substitution. This fluorinated compound is 5-fold more 
potent in healing rickets and elevating serum inorganic 
phosphorus levels of rachitic rats and in increasing intestinal 
calcium transport and calcium mobilization of vitamin D deficient 
rats. Falicalcitral is 10-fold more active than Vitamine D3. 
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1.7 Chemistry of β-nitrostyrenes 
1.7.1 The Chemical properties of β-nitrostyrene 
NO2
-nitrostyrene, 1a 
β-Nitrostyrene [1a] is the parent member of the aryl-nitroalkene family, and is a yellow 
crystalline solid of molecular weight 149 g/mol. It dissolves in organic solvents such as 
acetone, ethanol and dichloromethane, but not in water. It has a partition coefficient 
(octanol/water) of 59 and a melting point range of 58-59°C114, 115. 
 
1.7.2 The nature of nitroalkenes and their applications in chemistry 
Nitroalkenes are, generally prepared by the aldol condensation between carbonyl 
compounds and nitroalkanes via the β-nitroalcohol intermediate (nitroaldol) and this is 
known as the Henry reaction (Scheme 9). This reaction has found widespread application 
in synthetic organic chemistry116-123.  
 
O
R1 R2
R3 NO2
base R
2
R1
R3
NO2
OH
-nitroalcohol
dehydration
R2
R1
R3
NO2
nitroalkene
Henry reaction
 
 
Scheme 9: General synthesis of nitroalkenes 
 
Dehydration of the β-nitroalcohol intermediate forms nitroalkenes and these compounds 
have found a variety of applications such as Michael acceptors117, 124-131, dienophiles118, 132-
141, domino reactions142, masked ketones143-145, pyrrole formation146, 147, Friedel-Crafts 
alkylation148, 149.  
 
 
 
Applications: 
Michael acceptors 
Dienophiles 
Domino reactions 
Pyrrole formation 
Friedel-Crafts alkylation 
Masked ketones 
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The Henry reaction is characterized by:  
a) Reaction products that are usually formed as diasteriomeric syn- and anti- 
mixtures. The modification of the experimental conditions can result in the isolation 
of β-nitro alcohols with high diastereoselectivity. 
b) A variety of ionic and non-ionic bases can be used including: sodium hydroxide 
(NaOH), potassium hydroxide (KOH), sodium methoxide (CH3ONa), potassium 
methoxide (CH3OK), potassium tert-butoxide (t-BuOK), ammonium acetate 
(CH3COONH4), sodium carbonate (Na2CO3), potassium carbonate (K2CO3), 
potassium fluoride (KF), solid supported bases, amines, 1,5-
diazabicyclo[5.4.0]undec-ene-5 (DBU) and 1,5-diazabicyclo[5.4.0]nonene-5 (DBN). 
c) Only catalytic quantities of base are required and mildly basic conditions are 
necessary for the dehydration. 
d) Typical reported yields are in the range 11 – 95%120, 133 (depending on types of 
catalysts and solvents used). 
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1.7.3 Some synthetic applications of nitroalkenes 
Diels-Alder or cycloaddition reactions 
Nitroalkenes can act as powerful electron withdrawing substituents which makes 
nitroalkene derivatives potent dienophiles, undergoing the Diels-Alder or cycloaddition 
reactions132 (Scheme 10).  
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Scheme 10: Novel class of di- N-oxy-β-lactam compounds by cycloaddition reactions 
 
Scheme 10 shows β-nitrostyrene has been used (4 equivalents in the reaction) to form 
regioisomeric products 43 and 44. The functions of β-nitrostyrene in this reaction are that 
they firstly act as an electron-poor diene in an inverse electron demand in the Diels-Alder 
reaction with enol ether, which is an electron rich compound. After that, the electron poor 
intermediate 45a (dipolarophile) reacts with another β-nitrostyrene to form 1,3-dipolar 
cycloaddition compounds [43 and 44]. Both first and second step reactions were done 
under high pressure (15 kbar); compound 45b, which is the β-lactam compound, was 
surprisingly simple to purify from compound 43 by using silica gel chromatography (eluted 
by an eluent containing triethylamine).  
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Michael addition reactions 
In addition, nitroalkenes are powerful electrophiles and form highly stable carbanions150 
that readily undergo asymmetric conjugate addition reactions with nucleophiles or 
radicals134, 151. β-Nitrostyrenes are also good acceptors in Michael addition reactions 
applied to some natural products130, shown in Scheme 11  
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Scheme 11: Novel Formation of isoxazoline N-oxide with Michael adduct compound. 
 
Whereby 11, a′ is added to the polarized nitroalkene derivative [b′] to form the adduct c. 
The Michael adduct [compound 46] could be made from c by electron and proton transfer. 
Alternatively, compound c could also form the isoxazoline N-oxide compound by ring 
formation. Itoh and Kishimoto129 discovered an interesting mechanistic feature that the 
isoxazoline N-oxide ring is generated by an induction of intramolecular nucleophilic attack 
by the nitronate anion to the carbon-oxygen bond fission of the furan ring. 
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Domino Reaction 
β-Nitrostyrene can be used in triple cascade organocatalytic reactions152 (domino 
reactions; Scheme 12) to prepare highly substituted nitro cyclohexene derivatives. 
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Scheme 12: Triple cascade organocatalytic reactions 
 
This reaction produced 47, and ent-47 with multiple stereogenic centres. The advantages 
of this reaction are low reaction time (16-24 hours at room temperature), and cost, 
including purification of intermediates and steps avoiding the protection and deprotection 
of functional groups. It is greener chemistry, as the reaction is environmentally friendly in 
that organocatalysts are used that are non toxic, the reaction is highly efficient, starting 
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materials are readily available and are metal-free and compounds with excellent 
stereoselectivities are often obtained142.  
 
Scheme 12 shows that the catalyst makes the enamine to be formed, which made the 
aldehyde to be selectively added to the nitrostyrene in Michael – type reaction. The 
hydrolysis process liberated the catalyst, which causing them to be able to form the 
iminium ion of α,β-unsaturated aldehyde to complete the conjugate addition with 
compound A. In the third step, the enamine activation of intermediate B makes it possible 
for an intramolecular aldol condensation to form compound C. Further hydrolysis occurred 
to recycle the catalyst and release the desired product compound 47. 
 
Friedel-Crafts alkylation 
Another recent application of nitrostyrene compounds in chemistry is the enantioselective 
Friedel-Crafts alkylation of indoles with nitoalkenes catalyzed by different copper(II) triflate 
(Cu(OTf)2) bisoxazoline complexes (Scheme 13)149. 
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Scheme 13: Enantioselective Friedel-Crafts alkylation of indoles with trans- β-nitrostyrene 
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Nef reaction 
The Nef reaction provides protocol to form masked ketone [48] compounds from 
nitroalkenes (Scheme 14) 
NO2
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2. Nef reaction
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O
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Scheme 14: Formation of ketones via Diels – Alder and Nef reactions 
 
In summary, β-nitrostyrenes are versatile precursors for the synthesis of diverse chemical 
functionalities which are very reactive 1,3-dipolar reagents that can be converted into 
nitrile oxides, nitrones and nitronates117-119, 124, 125, 129, 133, 134, 142, 153. Therefore, β-
nitrostyrenes (and nitroalkenes) are excellent C – C bond forming agents and are used 
widely in organic synthesis to prepare novel compounds. 
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1.7.4 Other modern methods to synthesize β-nitrostyrenes 
Apart from the methods presented in Chapter 3, there are newer methods that recently 
have been used to make β-nitrostyrenes and a few of the methods provided a shorter 
reaction time, environmental friendly and excellent yield of the product. Alizadeh et al.132, 
154 developed a green method to synthesize β-nitrostyrenes using a cost-effective ionic 
liquid, 2-hydroxyethylammonium formate (2-HEAF), in the reaction. (Scheme 15) 
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Scheme 15: A green synthesis of β-nitrostyrenes 
 
They concluded the advantages of this reaction are this is a very clean and high yielding 
processing with no acid, base or metal catalyst required in the reaction. No side products 
were formed and all products were a crystalline forms which were easily characterized by 
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their melting points and spectroscopic data. As well as this one pot synthesis procedure 
avoided using hazardous organic volatile solvents and toxic catalyst, the reaction was 
done under room temperature and the use of cost-effective ionic liquids. The ionic liquids 
will be recovered in the procedure and can be used again. Overall commercially available 
and low-cost with high conductivity, great solvating ability and low melting point ionic 
liquids can be potentially used in other organic synthesis method. 
 
Yoshida et al.155 found the addition of dehydrating reagent, MgSO4, to the reaction can 
improve the yield (33% up to 81%) of β-nitrostyrenes when using excessive nitroalkane (5 
equivalents). Scheme 16 
CHO
+ H3C
NO2
NO2
CH2Cl2, MgSO4
NH2
COOLi
TBDPSO
O-tert-butyldiphenylsilyl L-tyrosine lithium
 
 
Scheme 16: Recent method of synthesizing β-nitrostyrenes 
 
The advantages of this method are good yields obtained and only a one step synthesis of 
the nitroalkene. As well as this the catalyst, O-tert-butyldiphenylsily L-tyrosine lithium salt, 
can play two different roles in the reaction: it helps to form the nitroalkene, and the 
catalyst can be used in the next step of reaction. This can help reducing the use of 
catalysts, in other words cost effective. However the longer reaction time (two days) it 
takes to synthesize the nitroalkene and organic solvent was used in the reaction become 
the disadvantages of this method.  
 
1.8 Microwave assisted Henry reactions 
Microwaves were used to assist the Henry Reaction in this project. Microwave irradiation 
(MWI) relies on the dielectric heating properties156-158. All dedicated microwave reactors 
for chemical synthesis generally operate with frequency at 2.45 GHz156, 159. This thermal 
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effect is dependent on the polar nature of specific solvent or reagents. There are two 
mechanisms which make solvents absorb microwave energy and convert it into heat. The 
dipolar rotation mechanisms, which results from dipolar polarization as a consequence of 
dipole-dipole interactions between polar molecules and the electromagnetic field158, or 
ionic conduction mechanisms which result when ions cluster in solution. The ions will 
circulate in solution by an electric field, the and collision rate will increase due to this 
movement in solution causing an expenditure of energy. The resulting kinetic energy is 
converted into heat157. Overall, the effectiveness of microwave irradiation is associated 
with the polarity of a molecule. 
 
Examples of microwave assisted Henry Reactions (Scheme 17)115, 160, 161 
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Scheme 17: Microwave assisted Henry Reactions 
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Microwave irradiation 
β-Nitrostyrene reacts with a carbonyl compound and an amine on alumina with microwave 
irradiation which is an efficient method of forming pyrrole compounds (Scheme 18)147.  
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Scheme 18: Formation and reaction of β-methyl-β-nitrostyrene using microwave irradiation 
 
1.9 Partition coefficients 
It is important to gain some idea of the permeability of a drug to pass through living 
cellular membranes. For this purpose, the partition coefficients (KD) of drugs need to be 
determined. Partition coefficients are used to determine the lipophilic nature of a 
compound. Solubility, permeability, oral absorption, cell uptake, blood-brain barrier 
penetration and metabolism of a compound are influenced by its degree of lipophilicity162. 
There are five key techniques for the determination of lipophilicity: solvent/water 
partitioning, chromatographic approaches, artificial membranes, electrokinetic approaches 
and partitioning between lipid/water phases162. A widely used technique to define the 
lipophilicity of a drug is the octanol/water partitioning163-165 and this technique was used to 
determine the lipophilicity of each nitrostyrene derivative prepared in this work.  
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Chapter 2 
 
2 Results and Discussion 
2.1 Introduction 
This chapter contains discussion of the synthesis and biological activity of nitroarenes, 
with emphasis on substituted 2-nitroprop-1-enyl benzenes. The antibacterial efficacy of 
the products was assessed by their activity against a panel of bacteria and a fungus 
(Candida albicans). The results appear as the minimum inhibitory concentration (MIC) for 
each compound. The partition coefficient (KD) between octanol and water for each 
compound, representing its degree of lipophilicity, was also determined in order to access 
the extent of its interaction with the surface of the microorganism. Compounds with the 
incorporation of fluorine were of considerable interest in these studies, particularly as 
earlier studies had indicated an improvement of antibacterial activity from this approach. 
Results are discussed in terms of structure-activity relationships that are important for 
activity against the microorganisms studied. 
 
2.2 Synthesis of 2-nitroprop-1-enyl benzene derivatives 
The Henry reaction was utilized for the preparation of most of the compounds. Two 
different conditions, referred to as Method A, Method B and other variations from the 
literature were used. 
 
Method A used methylamine as catalyst and was carried out at room temperature under 
mild alkaline conditions using sodium carbonate. Method B was performed in glacial 
acetic acid with ammonium acetate at 100°C or higher (see details in Chapter 3). In some 
cases Method A gave better yields than Method B, while in other cases, the reverse 
applied. Generally, the NMR data and mass spectrum of each compound were sufficient 
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as a guide for purity especially if the final melting point after recrystallization was sharp 
(range 1 - 2°C). 
 
2.3 The Henry reaction 
The Henry Reaction (refer to Chapter 1) can be used for the preparation of nitroalkenes 
and this reaction was the dominant reaction used in this project. The condensation was 
performed under various conditions. One technique was based on the method of 
Knoevenagel and Walter166. In this condensation reaction, the aldehyde and nitro 
compound react in the presence of potassium carbonate and methylamine in a solvent 
(ethanol) at room temperature. According to Crowell and Ramirez167, and Crowell and 
Kim168 the key reagent for this reaction is the amine, which acts as a catalyst in the 
reaction. The amine catalyst reacts with benzaldehyde to form an imine and water as a 
by-product. The water produced in the reaction, in fact, was found to have an appreciable 
effect on the yield, as it will shift the equilibrium of the reaction to the left, hence reducing 
the yield of the product167, 168. For this reason ethanol was introduced to reduce the 
influence of water and so optimize the yield168.  
 
A table below (Table 3) showed the structure, yield and melting points of compounds that 
have been synthezied in this research project. Synthesis methods and conditions can 
refer to Chapter 3 the experimental section. 
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Table 3: Synthesized compounds. 
R1
NO2
R2  
Compound R1 R2 Yield (%) M.P. (°C) 
1a H H 82 58-59 
1b 4-F H 57 99-100 
8b 4-OH CH3 50 121-122 
9b 3,4-dimethoxy CH3 27 71-72 
11 H CH3 22 60-62 
12a 2-F CH3 34 45-47 
12b 3-F CH3 52 NA 
12C 4-F CH3 30 65-66 
12d 2,4-difluoro CH3 43 48-49 
49a 2-CF3 CH3 46 NA 
49b 3-CF3 CH3 46 NA 
49c 4-CF3 CH3 42 96-98 
50a 3-OCF3 CH3 51 NA 
50b 4-OCF3 CH3 73 47-48 
51 
3- 
O2N
 
CH3 18 99-101 
52 4- CH3 CH3 80 54-55 
53a 1-naphth CH3 49 62-64 
53b 2-naphth CH3 41 90-91 
54a H phenyl-benzpyran 43 88-90 
54b H 4’ fluorophenyl-benzpyran 55 88-89 
55 H CH2CH3 60 NA 
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2.4 Structure-activity relationships (SARs) 
The important structural features studied were 
1. An aromatic ring (most compounds were based on β-nitrostyrene) 
2. A nitro group on alkenyl side chain 
3. Other substituents on the aromatic ring 
4. Variations in the structure of the side chain 
 
Most compounds tested for microbiological activity possessed an aromatic ring. Previous 
studies likewise have been carried out on aromatic compounds as it was thought that the 
flat surface of the aromatic ring could facilitate van da Waals bonding to other flat 
structures in the microorganism or other molecules that interfere with metabolism within 
the cell, such as enzyme inhibitors. Likewise, the nitro group was treated as a 
fundamental group for Investigation. The only variation being that one compound [51] 
(page 71) possessed two nitro groups. The side chain to which the nitro group was 
attached was unsaturated and was varied from two to four carbon atoms The compound 
with three carbon atoms (propenyl group) has been shown in previous studies22 to give 
superior activity to those with two carbon atoms. 
 
Other aromatic ring substituents included: –OH, -OCH3, -O-CH2-O-, -CH3, -F, -CF3, -OCF3, 
including multiple substituents or otherwise varied according to the position on the ring. 
Two unsubstituted compounds [1a and 11] were included as controls for these substitution 
effects. 
 
2.5 The importance of previous work 
The previous experimental results by Nicoletti et al. (unpublished work)29 influenced the 
direction of this project. Comparisons were made of activity against the bacteria and the 
fungus common to both studies. The Nicoletti et al studies showed that: 
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a) E. coli (Gram negative bacterium) was suppressed effectively by chloro or fluoro 
substituents at the 4-position relative to the side chain of β-methyl-β-nitrostyrene; β-
methyl-β-nitrostyrene with a methylene-dioxy ring substitution at positions 3- and 4- 
on the aromatic ring was not as effective.  
b) S. aureus (Gram positive bacterium) was suppressed effectively by a wide range of 
nitropropenyl arenes including β-methyl-β-nitrostyrene, the 4-fluoro and 4-chloro 
substituted derivatives of β-methyl-β-nitrostyrene. Imidazolyl, 3,4-dihydroxy and 
benzothiazole derivatives and the 3,4-methylene dioxy derivative were also very 
active. An important finding was that with two hydroxy groups in the 2- and 4- 
positions or the 2- or 5- positions, activity against this microorganism was noticeably 
reduced. The fact that this also occurred with substitution by N,N-dimethyl and N,N-
diethyl groups indicated that the more polar nature of these derivatives was 
detrimental to activity. This was supported by the KD values of the latter compounds 
being relatively low compared with the unsubstituted and halogenated-substituted 
compounds. 
c) B. subtilis (Gram positive bacterium) was suppressed by a wide range of compounds 
in a similar way to S. aureus and the dihydroxy substituted compounds [2,4- and 2,5- 
isomers] derivatives were unsatisfactory as chemical agents against this bacterium. 
However, 3,4-dihydroxy substitution gave high activity. 
d) C. albicans was suppressed by the 4-chloro and 4-fluoro derivatives, as well as the 
3,4-dichloro derivative. However 4-fluoro and the benzothiazole derivatives were also 
very active as well as 3,4-dihydroxy substituted compound. 
 
Previous results indicated that 3,4-methylenedioxy-β-methyl-β-nitrostyrene and many of 
the aromatic nitro compounds were not very effective against E. coli. The methylene dioxy 
group was not quite as effective as a simple –OH at position 3 relative to the side chain 
(3-hydroxy-β-methyl-β-nitrostyrene) or dihydroxy (positions 3 and 4 to the side chain). The 
4-fluoro substituent was superior to all other substitutions and also to the β-methyl-β-
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nitrostyrene. No improvement in activity was favored by the use of a combination of –OH 
and –OCH3 (3-hydroxy-4-methoxy-β-methyl-β-nitrostyrene and 2-methoxy-3-hydroxy-β-
methyl-β-nitrostyrene) or by 3,4-dimethoxy groups, although not all possible substituted 
positions were tested. These results suggested that compounds having some degree of 
hydrophilicity were the most effective against E. coli and this is borne out by the relatively 
low KD values of the most effective compounds (KD 65 – 150) compared with ineffective 
ones such as 3,4-methylenedioxy-β-methyl-β-nitrostyrene (KD 362). These compounds 
correspond to log10 KD values of 1.8 – 2.2, is often referred to as optimal Log P values for 
antibacterial activity.22 It could be speculated that for many Gram negative bacteria (such 
as E. coli) which are known to have polysaccharide structures, there would be greater 
affinity for hydrophilic compounds and hence passage through cell walls of these types of 
bacteria would be facilitated. For our results, the only Log P value for that can be cited for 
an effective fluorinated compound on E. coli (Gram negative) is 2.00 [12c]. For the Gram 
positive bacteria, a range of Log P values of 1.15 – 2.19 appeared to be related to efficacy. 
 
For the non-fluorinated compounds, optimal Log P values were over a much wider range 
from 1.61 – 3.41, and if C. albicans is included the range is even wider, from 1.15 – 3.41. 
 
2.6 Initial experiments 
The initial experiments were performed on key compounds that would be expected to 
provide acceptable standards for high activity. In this respect, 4-fluoro-β-methyl-β-
nitrostyrene was chosen as the most promising against E. coli and was compared against 
the 2-fluoro and 2,4-difluoro compounds. The 3,4-dimethoxy derivative of β-methyl-β-
nitrostyrene was also compared against the 3,4-methylene-dioxy compound. The 
unsubstituted compound was also tested in the main series of experiments. It was 
important to show that Method A (base catalysed reaction, which usually been used by 
Professor Hugh Cornell in this project) produced compounds of equal activity to those 
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prepared by Method B (ammonium acetate – acetic acid). Finally, the wide range of 
partition coefficients (KD values) of the compounds tested was wide (65 - 362) and 
therefore ideal for testing correlations with MIC values for both Gram positive and Gram 
negative bacteria. The results of these experiments are shown in Table 4, which lists the 
MIC values for each compound and their KD values. Three Gram positive bacteria 
(Staphylococcus aureus, Bacillus subtilis and Enterococcus faecalis), one Gram negative 
bacterium (Escherichia coli) and a fungus (Candida albicans) were tested in this program. 
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Table 4: Geometric mean MIC values in μg/mL and KD values for initial compounds tested 
against a fungus and a panel of bacteria.  
 
Strain Compounds and MIC values (μg/mL) 
 7 9b 12a 12c 12d 
S. aureus 2 2 8 2 4 
B. subtilis 2 2 3 4 2 
E. faecalis 4 5 5 5.5 6 
E. coli 256 128 42 27 45 
C. albicans 3 4 3 2 3 
Partition 
Coefficient 
(KD) 
362 250 138 101 65 
 
 
Figure 1: The compounds tested for antibacterial activity 
 
 
 
 
 
 
 
 
 
7: 3,4-methylenedioxy-β-methyl-β-nitrostyrene 
9b: 2-dimethoxy-4-(2-nitroprop-1-enyl)benzene (3,4-dimethoxy-β-methyl-β-nitrostyrene) 
12a: 1-fluoro-2-(2-nitroprop-1-enyl)benzene (2-fluoro-β-methyl-β-nitrostyrene) 
12c: 1-fluoro-4-(2-nitroprop-1-enyl)benzene (4-fluoro-β-methyl-β-nitrostyrene) 
12d: 1,3-difluoro-4-(2-nitroprop-1-enyl)benzene (2,4-difluro-β-methyl-β-nitrostyrene) 
 
The results in Table 3 were tested for correlation between MIC value and KD value for E. 
coli and E.facaelis. 
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Figure 2: Correlation between MIC value and KD value for E. coli 
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Figure 3: Correlation between MIC value and KD value for E. faecalis 
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The results suggest that KD values in the lowest range (65 – 138) are associated with high 
activity against E. coli whilst the opposite is the case for E.facaelis. Note the opposite 
gradients for each bacterium shown in Figures 4 and 5. 
 
 58 
There were no correlations between MIC value and KD value for S. aureus, B. subtilis, and 
C. albicans (graphs not shown) 
 
2.6.1 Effects of substituents 
 Compound 12c 
Of the five different compounds tested for antimicrobial activity, the most active compound 
was the one prepared from 4-fluorobenzaldehyde and nitroethane [1-fluoro-4-(2-nitroprop-
1-enyl)benzene] [12c]. This confirmed the results obtained by Nicoletti et al.29 using a 
panel of Gram positive bacteria, enteric and non-enteric Gram negative bacteria and fungi, 
in which a large number of compounds with different types of substitution on the aromatic 
ring were tested. There was no significant difference in activity between the two samples 
of the above compound, one prepared by Method A, the other by Method B. The lowest 
MIC values against E. coli (27µg/mL) were obtained with 12c (Refer to Table 4). MIC 
values against the other microorganisms were all less than 8µg/mL, hence all the 
compounds tested would be described as very effective against the three Gram positive 
bacteria and C. albicans. 
 
Compound 7 
With regard to the E. coli results, the least effective compound was compound 7. The 
compounds prepared from reaction of 2-fluorobenzaldehyde [12a] and 2,4-
difluorobenzaldehyde [12d] with nitroethane had slightly lower activity against E. coli than 
12c. The compound [9b] prepared from reaction of 3,4-dimethoxybenzaldehyde with 
nitroethane gave excellent results against all microorganisms except E. coli. However, the 
latter preparation gave results with E. coli that were comparable to commercial compound 
7. Nicoletti et al.(unplublished work)29 also evaluated some aromatic nitropropene 
compounds with –OH and –OCH3 substitution and found that those with one –OH and one 
-OCH3 were the most promising. The compound with dimethoxy substitution [9b] had high 
activity against the three Gram positive bacteria and the fungus common to both 
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experiments but was inferior to 12c against the gram negative E. coli. It did, however, 
show relative higher activity than compound 7 (Table 4). 
 
There was a good correlation (Figure 2) between the effectiveness against E. coli and the 
partition coefficients of the compounds tested (r2 = 0.9237). Thus for high effectiveness 
against E. coli, compounds with low KD values are indicated to be the most effective, i.e. 
compounds with low lipophilicity. In Figure 3, there is also a good correlation (r2 = 0.8777) 
between the effectiveness against E. faecalis and the partition coefficients of the 
compound tested. The results show that for high effectiveness against E. faecalis, 
compounds with high KD values are the most effective, i.e. compounds with high 
lipophilicity. E. faecalis is an enteric bacterium and its cell wall structure governs 
penetration of antibacterial compounds. High KD values appeared to be favoured for high 
activity. No conclusions could be drawn concerning correlations with other Gram positive 
bacteria as the MIC values were all in the range 2-3. Likewise MIC values for C. albicans 
were also very low. Milhazes et al.22 used E. coli, E. faecalis and S. aureus for test on 
various nitrostyrene derivatives, but found no correlation between MIC values and 
lipophilicity on E. faecalis and S. aureus. 
 
The reason for the effectiveness of fluorine substitution on the aromatic ring is probably 
connected with the high electronegativity of fluorine, although size factors could also be 
important. Perhaps the electronegativity of fluorine could affect binding affinity to the 
binding site of the bacteria, thus causing inhibition of the enzyme. 
The results indicate that further experiments with fluorine substitution would be valuable 
as a way of determining the structural features required for the optimal anti-bacterial 
activity of nitro compounds of this type. Fluorine substitutions made on both the ring and 
side chain will be attempted in order to present a clearer picture of structure-activity 
relationships and possible mechanisms of action. 
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2.7 Discussion of structure – activity relationships (SARs) 
This section will focus on the effectiveness against the chosen bacteria and fungi of the 
main series of compounds investigated. For chemical structures of compounds refer to 
Table 5 page 69 and 70. 
 
2.7.1 Hydroxy and methoxy substituted compounds 
See 8a, 8b, 8c, 9a, 9b, 10a, 10b against 11 (no substitution) and refer to Table 5 
1. One substituent –OH group 
One –OH in 3-position [8a] to the side chain made marginal changes to the activity 
compare to the unsubstituted compound [11] and a small increase in KD values 
(113 to 145) was not consistent with the slightly better result against E. coli caused 
by the substitution. The compound with substitution on the ring in 4-position [8b] 
with slightly higher in KD values than 8a showed better results against tested 
bacteria except result against E. coli which both of them had obtained the same 
MIC values (64). 
2. Two –OH groups 
Two –OH groups, at position 3 and 4 relative to the side chain [8c] made a small 
improvement with the Gram positive bacteria relative to 8a, but there was no 
change in activity against E. coli, the latter observation being consistent with 
virtually the same KD value. The result with C. albicans was excellent (MIC 4). 
3. –OH and –OCH3 together  
10a with –OH at position 3 and –OCH3 at position 4 to the side chain failed against 
C. albicans, as did 10b with these positions reversed. This suggested that, as both 
of these compounds were reduced in effectiveness against C. albicans compared 
with the unsubstituted compound [11], high polarity effects of these groups 
reduced the activity against this fungal material. Both still maintained reasonably 
high activity against the Gram positive bacteria but the activity of 10a against E. 
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coli was somewhat lower than 10b, the latter being about the same as the 
unsubstituted compound. 
4. One substituent –OCH3 group 
A substitution of a –OCH3 group in 4-position [9a] relative the side chain also 
changes the activity compared to the unsubstituted compound [11] giving a much 
more active compound against the chosen bacteria (same results obtained as 
compound 8b) although a huge increase in KD values (113 to 479) had occurred. 
These results, suggest that substitution in 4-position of the ring could optimize the 
activity of the parent compound [11] against the Gram positive, Gram negative 
bacteria and the fungus. 
5. Two –OCH3 groups  
Compound 9b with –OCH3 groups at positions 3 and 4 to the side chain gave 
excellent results on C. albicans and the Gram positive bacteria, in complete 
contrast to 10a and 10b with adjacent –OH and –OCH3 groups. It could be argued 
that this was due to optimal polarity effects, but it does not explain why compound 
8c with its two hydroxy groups is also of excellent activity against C. albicans 
whereas the compounds with one of each type of substituent [10a and 10b] are 
much inferior. 
 
Activity of 9b against E. coli was slightly less than 10b and similar to that of 10a. 
For these –OH and –OCH3 substitutions it appears that the main achievements were 
improved activity against Gram positive bacteria and Candida albicans, seen with 
substitution at position 3 and 4 with –OH groups [8c] and –OCH3 groups [9b]. However, it 
must be pointed out that most of these substitutions only marginally improved the activity 
and in two cases [10a and 10b] with one of each group as a substituent, there was a large 
decrease in activity against C. albicans. Milhazes et al.22 found a dihydroxy derivative to 
be the most active against Gram negative bacteria, which agrees with the results obtained 
on E. coli. 
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Several other compounds also showed high antibacterial activity, particularly compounds 
8b or 9a, which compared favourably with compounds with –OH and –OCH3, substitutions 
previously tested against E. coli. Compounds 8a and 8c (Nicoletti et al.29) were more 
active than 7 and are marginally better than the non-substituted compound 11 and 
compound 10b [1-hydroxy-2-methoxy-4-(2-nitroprop-1-enyl)benzene]. These results 
indicate that one –OH group gave some enhancement of activity against E. coli, (e.g. 
compound 8a) as well as compound 8c (with two OH groups on adjacent carbon atoms). 
However, compounds 10a and 10b each with one hydroxy group and one methoxy group 
were not as active and compound 9b with adjacent methoxy groups was also less active. 
 
With compound 8b (4-hydroxy), two comparisons can be made against 9a (4-methoxy) 
with –OCH3 instead of –OH, and against compound 11, which has no ring substitutions. 
The activities of 9a and 8b are almost identical yet 9a has much higher KD than 8b (479 
against 150). All results except those with E. coli are excellent. 
 
Results were generally better with compound 8b (4-hydroxy) than for Compound 11 
against the chosen Gram positive bacteria, but were the same for E. coli and C. albicans, 
suggesting the substitution of –OH [8b] and –OCH3 [9a] had improved the potency against 
Gram positive bacteria. KD values of 479 [9a], 150 [8b] and 113 [11], suggested that a 
more lipophilic nature is tolerated for antibacterial properties in the case of Gram positive 
bacteria. 
 
The compounds 8a (3-hydroxy), 8c (dihydroxy) 10a and 10b (Table 5) are included to 
offer further comparisons with the work of Nicoletti et al.29 They have similar good activity 
against the Gram positive bacteria, but the activity of Compounds 10a and 8c is inferior to 
the others against E. coli and 10a and 10b have the lowest activity of all compounds in 
Table 5 against the fungus. The reasons are possibly related to the presence of the polar 
hydroxy group in 8a, 10a and 10b. Compound 8c, with two methoxy groups, is the best of 
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this series of compounds. Referring again to Table 4, it is seen that Compound 9b (3,4-
dimethoxy substitution) is very active against Gram positive bacteria, but lacks activity 
against E. coli. 
 
2.7.2 Fluorine substitution on the ring  
The effects of different fluorine substitutions on the aromatic ring on biological activity 
were explored further in order to determine which groups enhanced the activity of β-
methyl-β-nitrostyrene [11], which was the main parent compound investigated. Previous 
results of MIC determinations on twenty different selected compounds, showed that 4-
fluoro-β-methyl-β-nitrostyrene had the highest antimicrobial activity across the range of 
microorganisms tested (Nicoletti et al.29). It was pointed out that tests were performed 
using a large panel of Gram positive bacteria, Gram negative bacteria and fungi. In the 
present series of tests, a smaller panel of bacteria and a fungus were used to test the 
activities of compounds (see Fig 4). The results are shown in Table 5, the most active 
compounds against E. coli were compounds 8a, 8b, 8c, 9a and 12c; all with MIC values of 
64 µg/mL. Results with compound 11 (no substitution) indicated that the basic structure of 
β-methyl-β-nitrostyrene already has slightly lower activity against this bacterium compare 
to compounds 8 (a, b, and c) 9a and 12c. Substitution on the ring with –OCH3, -OH, -CF3 
and -F only marginally improved this activity. However –OCF3 substitution has caused a 
large reduction in activity, this maybe due to an opposing electronic effect of the oxygen 
atom, as this effect was not noticed with –CF3. Results against the Gram positive bacteria 
and the fungus Candida albicans were generally good to excellent. More detailed analysis 
and comparisons follow. 
 
The results again showed that the halogenated derivatives had enhanced potency, with 
12c having lower MIC values than 7, the difference being seen clearly with the Gram 
negative bacterium E. coli. The early results (Table 4) again indicated that there was a 
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relationship between the MIC value and the KD value for the compounds studied (r2 = 
0.5066, graph not shown). The interpretation of this relationship is that the low KD value, 
representing a lower degree of lipophilic character, is necessary for disruption of the 
polysaccharide-rich membrane of the membranes of Gram negative bacteria. 12c has a 
much lower KD value than 7 (Refer to Table 4). The lower value of r2 for this batch of 
results (Table 5) compared with results in Table 4 was due to the greater diversity of 
structures and KD values (e.g. –CF3, -OCF3, OH, OCH3, dinitro compound) and side chain.  
 
Compound 12c gave better results (64 MIC) against E. coli than 7 (MIC 128). The partition 
coefficient (KD) of 12c is lower than that of 7 and further studies of KD values against MIC 
values were carried out to investigate the value of this test. Fluorine substitution shows 
effective enhancement of activity, with excellent results not just on E. coli, but also against 
all bacteria except E. faecalis. Compounds 8a (3-hydroxy), 8b (4-hydroxy), 8c (3,4-
dihydroxy), 9a (4-methoxy) and 12c (refer to Table 5) all gave the same good results 
against E. coli. However, as noted in Table 4, compound 9a has a larger KD compared to 
7. This suggested that lipophilicity of the compounds would not be the only factor or the 
dominant factor in activity against the chosen bacteria and may not apply to all the Gram 
positive bacteria. 
 
Compound 9a (4-methoxy substitution) gave excellent results against Gram positive 
bacteria as did 12c yet 9a and has much higher KD than 12c (479 against 101). This 
suggests that low KD values are not required for high activity against Gram positive 
bacteria. Interestingly, this is opposite to what was generally observed for the Gram 
negative bacterium E. coli. Compounds 8b (4-hydroxy) and 49c (4-trifluoromethyl) have 
identical results to 9a with all the microorganisms tested excepted E. coli (49c has MIC 
values of 96). Compound 9a gave much better results (MIC 64) against E. coli than 
compound 50a (4-trifluoromethoxy) (MIC 512). Fluorine substitution of this type has 
detracted from activity with other bacteria and the fungus. Comparisons of activity with 
 65 
Gram positive bacteria demonstrated that the KD is not the main factor involved in activity 
against the bacteria as 50b has a lower KD than 9a. The structures are quite different and 
will govern KD values. 
 
No improvement in antibacterial efficacy was found by the use of other fluorine containing 
substituents such as –CF3 and –OCF3. In fact, the latter group was greatly detrimental 
when substitution at the 4 position to the side chain was effected (compare 49c with 50b). 
At positions C-2 and C-3 the –CF3 detracted from activity against E. coli, indicating that 
this type of substitution may be interfering with the antimicrobial effect, e.g. by blocking 
access of the reacting species. 
 
Compound 49c (4-trifluoromethyl) has a similar structure that of 50b (4-trifluoromethoxy), 
except for the extra oxygen atom attached to the –CF3. They both gave similar 
antibacterial results, except for E. coli. 50b has a much higher MIC against E. coli (MIC 
>512) than 49c, which is expected due to the KD for 50b being 155 and being 68 for 49c. 
Compound 49c has quite good activity (MIC 96) and similar to the compounds with 
fluorine on the aromatic ring. 
 
2.7.3 Other non β-methyl-β-nitrostyrene based compounds  
The introduction of a second nitro group by the use of terephthaldehyde [51] was also 
seen to be an important factor for study. Comparisons were made against the standard, 
unsubstituted aromatic compound [11]. The main series of microbiological tests included 
compounds with the naphthalene [53a, 53b] instead of the benzene ring of β-methyl-β-
nitrostyrene. A nitrochromene compound [54a] was also tested, along with the fluorine 
derivative [54b]. All the compounds tested, except compounds 10a and 10b, showed 
good to excellent activity against the fungus Candida albicans. With regard to the Gram 
positive bacteria, all the compounds tested showed good to excellent activity with several 
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[9a, 8b, 49c, 50b, 51a, 52 and 11] being comparable to 12c, in accordance with the 
results of previous studies (Nicoletti et al.29). Hence, so far, it can be concluded that all of 
these nitrocompounds appear to belong to a class of compounds which are quite effective 
as antimicrobial agents.  
 
The two nitropropenyl groups of compound 51, compared to compound 11, proved to be 
detrimental in activity against E. coli. A considerably higher KD was also observed with 51; 
however, results for the Gram positive bacteria and the C. albicans all were excellent. 
All these compounds have large KD values. Nitrochromene [54a] was not active against E. 
coli to any appreciable extent and there was no improvement with fluorine substitution 
[54b]. Generally for E. coli inhibition the more hydrophilic compounds, with lower KD 
values, performed better than those with higher KD values. 
In summary, fluorine substitution on the ring at position 4 [12c] was slightly better than 
substitution with –OH [8b] and –OCH3 [10b], –CF3 [49c] and no ring substitution [11] 
against E. coli. The initial series indicated 1-fluoro-4-(2-nitroprop-1-enyl)benzene as the 
most active, and all compounds had very good activity (MIC 2-27) against S. aureus, B. 
subtilis and E. faecalis. 
 
2.8 Results with E. faecalis and E. coli 
By considering E. faecalis (Gram positive) and E. coli (Gram negative) the influence of 
substitutents is apparent as the MIC values are higher than for other bacteria and the 
fungus. 
 
E. faecalis  
 -OCH3, -OH, -CF3 at 4-position, -OCF3 at 4-position, the dinitropropenyl compound 
prepared from terephthaldehyde [51], 7 and 12c, and unsubstituted β-methyl-β-
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nitrostyrene [11] all had high activity. There was no obvious benefit of any 
substitution. 
 The best performance (MIC 4) was seen with the 2-naphthyl derivative [53b]. The 
1-naphthyl derivative [53a] was distinctly less active but a good result (MIC 32) 
was obtained against this Gram positive bacterium.  
 3-fluoro and 4-fluoro substitution on the ring [12b, 12c] gave very good results 
respectively (MIC 16), akin to the results with 7 results and no substitution [11]. 
 Good results (MIC 32) were also obtained with compound 52 (CH3 at position 4), 
the 1-naphthyl derivative [53a].  
 The nitrochromenes (MIC both 128) were only moderately active. 
 The β-nitrostyrene [1a] compound made from nitromethane was inferior (MIC 128) 
to the β-methyl- β-nitrostyrene derivative [11] (MIC 16). Activity was improved by 
substitution at position 4 with fluorine [1b], but not to the extent as with 12c. A 
methyl group at position 4 [52] showed no antibacterial enhancement (MIC 32 
against 16 for the unsubstituted compound, 11).  
 
E. coli 
 Compound 7 was not significantly active against E. coli (MIC 128). 
 Fluorine substitution at position -4 [12c] enhanced activity but fairly good results 
were obtained without any substitution [11] (MIC 92). 
 An –OH group at position -3 or -4, two –OH groups at position 3 and 4, an -OCH3 
at position 4, and –CF3 at position 4 gave compounds that were all fairly active 
(MIC 64). 
 An –OCF3 at position 4 [50b] caused a sharp drop in activity compared to the 
same substituent at position 3 [50a].  
 The terephthaldehyde product [51] had extremely poor activity (MIC > 512) in 
complete contrast with the result against E. faecalis (MIC 2). 
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 The product with 2-OCH3 groups or one with an –OH and -OCH3 were only of 
moderate activity [10a and 9c] 
 Best results (MIC 64) were obtained with 3-OH [8a], 4-OH [8b], 3,4-dihydroxy [8c], 
4-OCH3 [9a], 3,4-dimethoxy [9b] 4-fluoro [12c], 4-CF3 [49c] and parent compound 
[11]. 
 Substitution with fluorine at the 3-position [12b] reduced the activity of the 
unsubstituted compound [11] (MIC 256 compared with 96). 
 Substitution with –CF3 at position 2 [49a] gave a very unsatisfactory result (MIC 
512). 
 In contrast to the E .faecalis results, the naphthyl derivatives were both very poor 
and the 2-naphthyl derivative [53b] (best with E. faecalis) gave the worst result of 
all (MIC>512). 
 The nitrochromene derivatives [54a and 54b] were both poor (MIC 256) and both 
were worse than the unsubstituted compound [11] made from nitroethane. 
Substitution with fluorine was of no consequence. 
 
Against E. coli, the most active compounds were compounds 8a, 8b, 8c, 9a and 12c; all 
with MIC values of 64 µg/mL. Results with compound 11 (no substitution) indicated that 
the basic structure of β-methyl-β-nitrostyrene already has a high activity against this 
bacterium. Substitution on the ring with –OCH3, -OH, -CF3 and –F have only marginally 
improved this activity.  
 
Results against the Gram positive bacteria and the fungus Candida albicans were 
generally good to excellent. More detailed analysis and comparisons follow. 
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Table 5: Microbiological evaluation of nitropropenyl arenes. Figures are MIC values in μg/mL 
Strain Compounds and MIC values (μg/mL) 
 1a 1b 7 8a 8b 8c 9a 9b 10a 10b 11  12b 12c 
Staphylococcus 
aureus 
256 128 8 13 2 2 2 2 16 16 8 8 8 
Bacillus subtilis 256 256 8 6 2 6 2 2 16 16 16 16 8 
Enterococcus 
faecalis 
128 64 8 ND 4 ND 4 5 ND ND 16 16 16 
Escherichia coli 256 256 128 64 64 64 64 128 161 81 96 256 64 
Candida albicans 32 32 8 19 4 4 4 4 128 128 6 8 4 
Partition 
Coefficients (KD) 
51 62 362 145 150 111 479 250 41 186 113 14 101 
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Continuation of Table 5 
Strain Compounds and MIC values (μg/mL) 
 49a 49b 49c 50a 50b 51 52 53a 53b 54a 54b 55 
Staphylococcus 
aureus 
16 16 2 16 2 4 8 16 4 64 32 64 
Bacillus subtilis 8 8 2 8 4 2 16 16 4 128 64 8 
Enterococcus 
faecalis 
32 16 4 16 8 2 32 32 4 128 128 16 
Escherichia coli 512 256 96 256 512 >512 128 512 >512 256 256 256 
Candida albicans 16 8 4 8 8 2 16 16 4 64 32 8 
Partition 
Coefficients (KD) 
60 30 68 18 155 556 453 1492 2561 280 429 70 
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Figure 4: The correlations between MIC and KD values for each organism 
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E.faecalis
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C.albicans
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Please note that in C. albicans KD-MIC correlations a reversal of the slope/gradient was 
observerd. 
 
2.8.1 Results with Gram positive bacteria 
Results against the Gram positive bacteria (including the previous data of Nicoletti et al.29) 
indicated that the growth of this group of bacteria is more readily suppressed by β-methyl-
β-nitrostyrene than in the case of E. coli. Structure activity relationships were only able to 
be followed on Enterococcus faecalis as nearly all results on S. aureus and B .subtilis 
were excellent. In the case of some compounds notably 7, the compound with –OCF3 
substitution at position 4 [50b], the terephthaldehyde product [51] and a naphthalene 
derivative [53b] there was a complete turnaround from extremely poor results with E. coli 
to extremely good results with E. faecalis (MIC values 8 or less). In contrast to the E. coli 
results, the compounds with high KD values performed much better than those with low KD 
values suggesting that the more hydrophobic the compound was the better it performed 
against E. faecalis. Performance of compounds of this type was excellent against the 
other Gram positive species, S. aureus and B. subtilis with MIC values all in the range 2-
16. Correlation between effectiveness against Gram positive bacteria were only able to be 
tested against E. faecalis. Figure 4 shows that a good correlation was obtained for the 
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particular compounds tested with negative gradient, the opposite to those with E. coli. 
 
2.8.2 Results with Candida albicans 
For Candida albicans, all compounds, irrespective of their activity against the Gram 
positive or Gram negative microorganisms, performed extremely well with MIC values in 
the range 2-16, the only exceptions being the following: 
 Two hydroxy – methoxy substituted compounds from previous studies [10a] 
and [10b] (both MIC 128) 
 
The reason for the lowering of activity of these compounds against C. albicans, seen 
strikingly in the two hydroxy – methoxy compounds [10a and 10b] compared with the two 
unsubstituted compounds (β-nitrostyrene [1a] and β-methyl-β-nitrostyrene [11]) is 
unknown. However, the results of these compounds [10a and 10b] with E. coli are also 
unimpressive and may be due to the effects of two polar groups causing significant 
blocking of an otherwise interactive site. The 3,4-dihydroxy derivative [8c] gave an 
excellent result and highlights the importance of the positions of substitution in interactions 
between the compounds and receptor sites on the microorganism.  
 
Substitution of β-methyl-β-nitrostyrene with fluorine at the 4-position [12c] resulted in a 
slight increase in activity against Candida albicans (12c against 11). The results of 
substitution with –CF3 at the 4-position produced no change in activity, but –OCF3 at this 
position may have attenuated the activity (compare 49c, 50b and 11). The unsatisfactory 
results with both nitrochromenes [54a and 54b] may be due to blocking by groups in the 
vicinity of the nitro group (oxygen atom and aromatic ring). These compounds likewise did 
not perform well against the bacteria. 
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2.9 Summary of SARs results  
2.9.1 Substitutions on aromatic ring 
1. –OH vs. –OCH3 (8b vs. 9a) 
The activities were identical with excellent results against all microorganisms 
except E. coli, which gave an MIC of 64 in each case. The result for the 
methoxy substituted compound is surprisingly good, especially considering its 
high KD value (479). The results are somewhat better than the parent 
compound [11]. 
 
2. –OCH3 vs. –OCF3 (9a vs. 50b) 
The methoxy substitution proved vastly superior to the trifluoromethoxy group 
in tests against E. coli (MIC 64 against 512). However, in the tests against 
other bacteria and C. albicans, both substitutions were observed to be slightly 
better than no substitution [11], the major difference being that activity against 
E. coli was adversely affected as mentioned above. For this group of 
compounds, the KD values were not reliable indicators of activity against E. coli. 
 
3. –CF3 vs. –OCF3 (49c vs. 50b) 
The results with –CF3 were excellent against all the microorganisms tested 
except E. coli. The compound [49c] still had fairly high activity (MIC 96) making 
it comparable to one without substitution, but the –OCF3 substitution destroyed 
the activity against E. coli. The KD value of compound 49c was only 68 and 
indicative of its superiority to 50b (KD 155) against E. coli. 
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4. –CH3 vs. –CF3 (52 vs. 49c) 
The methyl group at position 4 gave similar results to the –CF3, suggesting that 
the fluorine substitution for hydrogen had no significant effect on activity across 
the range of microorganisms tested despite the huge differences in KD values. 
 
5. –F vs. –CF3 (12c against 49c) 
The excellent results reported for –F substitution at position 4 was only 
marginally better than those for –CF3 at the same position. Nevertheless, -F 
substitution remains the best type for overall high activity against the Gram 
negative, Gram positive and fungal microorganisms tested. 
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The Gram positive bacteria tested were most effectively inhibited by the following 
substitutions shown in Table 6. 
 
Table 6: Most effective compounds against the Gram positive bacteria 
Structure Bacteria (MIC) 
HO
NO2
8b  
S. aureus (2) 
B. subtilis (2) 
E. farcalis (4) 
H3CO
NO2
9a  
S. aureus (2) 
B. subtilis (2) 
E. farcalis (4) 
NO2
H3CO
H3CO
9b  
S. aureus (2) 
B. subtilis (2) 
E. farcalis (5) 
F3C
NO2
49c  
S. aureus (2) 
B. subtilis (2) 
E. farcalis (4) 
51
NO2O2N
 
S. aureus (4) 
B. subtilis (2) 
E. farcalis (4) 
NO2
53b  
S. aureus (4) 
B. subtilis (4) 
E. farcalis (4) 
 
These products were also the most effective against the fungus Candida albicans and 
were likewise superior to the unsubstituted parent compound. 
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Relative activities of compounds 
The relative activities of some compounds are summarized Table 7. 
 
Table 7: Relative activities of some compounds 
Relative activities Structure 
Has the best activity against E. coli, and was also excellent against 
C. albicans and very good against S. aureus and B. subtilis. 
12c 
It does not show results for E. coli as good as 12c, but it is 
comparable on Gram positive bacteria and fungus. 
7 
Compounds showed excellent activity against the Gram positive 
microorganisms and the fungus 
8b, 8c, 9a, 9b, 49c, 
50b, 51 and 53b# 
These compounds have relatively high activity against E. coli 
8a, 8b, 8c, 9a, 9b, 
10b, 11, 12c and 49c 
Very poor activity against E. coli (MIC > 512) in contrast to their high 
activity against the Gram positive bacteria and the fungus 
49a, 50b, 51 and 53b 
There was very good agreement on the compounds tested by 
Nicoletti et al. 
7, 12c, 8a, 8c, 10a 
and 10b 
 
 #Note: The KD values of 556 [51] and 2561 [53b] were quite the opposite of the low KD 
values associated with activity against E. coli. 
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2.10 The effect of different substitutions on lipophilicity 
In Chapter 1 lipophilicity was discussed as an indicator of the permeability of a drug to 
pass through living cellular membranes. In this section, the results of the effect of different 
substituents on lipophilicity are presented. Substitutions of –F, -CF3, -OCF3, -OH, -OCH3 
and the combination of the latter two were studied and are shown in 2.9.1. Figure 5. E. 
coli gave better correlations than the other tested bacteria and fungus even though they 
were not as good as the correlations shown in Fig 2. It still shows that low KD values 
generally work better against E. coli than the compounds with higher KD values. 
 
Although compound activity again did not correlate with KD values, the Gram positive 
bacteria did not display good correlations. Compounds with high KD values are more 
compatible/effective against the Gram positive bacteria. This is also the case with C. 
albicans. 
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2.10.1 Summary of tested substitutions on β-methyl-β-nitrostyrene 
Figure 5: Various substitutions on β-methyl-β-nitrostyrene 
 
1. Fluorine atom(s) substitution, -F  
 
2. Trifluoromethyl substitution, -CF3  
 
 
 
 
3. Trifluoromethoxy substitution, -OCF3  
 
 
 
 
4. Hydroxy substitution, -OH 
 
 
 
 
5. Methoxy substitution, -OCH3 
 
 
 
 
6. Hydroxy and methoxy substitution, -OH and –OCH3 
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2.10.2 Summary of results of lipophilicity studies 
The results obtained showed, surprisingly, that changing the position (-2, -3, -4) of the 
fluorine atom on the aromatic ring (12a, 12b, and 12c, Table 8) altered the lipophilicity of 
the parent compound [11] by either increasing KD slightly or decreasing KD. This was 
especially noted with 12b, in which the 3-position of substitution gave a very low KD (14). 
Compound 12d with two fluorine atoms substituted on the ring also decreased the 
lipophilicity of compound 11 by half (KD 65). However, only 12a gave a larger KD value 
(246, refer to Table 4) than compound 11. (KD 113) 
 
The lipophilicity results of compounds 49a, 49b and 49c showed that substitution of a 
trifluoromethyl group on the ring decreased the KD value (repective KD values 60, 30, 
68)of the parent compound [11] by about a half. Substitution on position 3 gave the lowest 
KD value out of the group. 
 
Substitution on position 3 of the ring of a methoxy group [50a] again showed an extremely 
low KD value (KD 18), this being lower than other derivatives. Compound 50b was similar 
to 12c both compounds having higher KD values (KD 155 and 101) than the parent 
compound [11].  
 
It can be seen by reference to Table 9 that hydroxy group substitutions gave similar 
results to the fluorine atom but substitution on position 3 [8a] still results in a lower KD 
value than substitution on position 4 [8b] even though the difference of 8a and 8b in KD is 
not large. The dihydroxy compound remains the lowest KD (111) of the other two 
derivatives and has a slightly lower KD than compound 11, while 8a and 8b did not have 
lower KD values than compound 11. 
 
Substitution on the 4-position showed the same result as previously; a large KD was 
obtained that was significantly larger than the parent compound [11]. The dimethoxy 
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substitution [9b] gave a product having KD about half that of the monosubstituted 
compound [9a], and the result is similar to the other two di-substituted compounds (8c and 
12d). However, the KD of 9b is still greater than compound 11.  
 
A small KD (41) was obtained on compound 10a, in which a hydroxyl group is located at 
the 4 position of the ring. The value of KD increased to back over 150 when the –OH group 
was moved to position 4, which also happened with compound 8b. 
 
In summary, low KD values compounds usually mean high efficiency against E. coli (Gram 
negative bacterium), while high KD values compounds generally are more effective against 
Gram positive bacteria. For the fungus, all compounds generally have good antibacterial 
activity even with high or low KD values. However, the KD values can only be used as a 
guide to estimate whether a compound is likely to be effective against the bacteria being 
tested. Some compounds, for example 12b and 12d, have lower KD values than 12c, but 
they do not have comparable activity to 12c against E. coli. 
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Table 8: KD values of fluorine-substituted derivatives of β-methyl-β-nitrostyrene  
Compound Substitution KD 
12a 2-fluoro 138 
12b (8a and 
10a) 
3-fluoro (3-hydroxy and 
3-hydroxy-4-methoxy) 
14 (145 and 
41) 
12c (8b) 4-fluoro (4-hydroxy) 101 (150) 
12d 2,4-difluoro 65 
49a 2-trifluoromethyl 60 
49b 3-trifluoromethyl 30 
49c 4-trifluoromethyl  68 
53 4-methyl 60 
50a (10b) 3-trifluoromethoxy (3-methoxy-4-hydroxy) 18 (186) 
50b (10a) 4-trifluoromethoxy (4-methoxy) 155 (479) 
1a No ring substitution, no methyl substitution 51 
11 Parent compound 113 
 
Table 8 shows KD values of the various fluoro derivatives tested. Note the low values of KD 
as the result of substitution at the 3-position by –F, -CF3, -OCF3. Correlation between 
activity and KD values were not suggestive of a relationship. Results in brackets are 
intended for comparison. 
 
Table 9: KD values of hydroxy and methoxy derivatives of β-methyl-β-nitrostyrene 
Compound  Substitution KD 
7 3,4-methylenedioxy 362 
8a 3-hydroxy 145 
8b 4-hydroxy 150 
8c 3,4-dihydroxy 111 
9a 3-hydroxy-4-methoxy 41 
9b 3-methoxy-4-hydroxy 186 
10a 4-methoxy 479 
10b 3,4-dimethoxy 250 
11 None 113 
 
Table 9 lists the KD values of compounds with hydroxy and methoxy substitutions showing 
the general tendency for KD to be raised by methoxy, dimethoxy and methylene dioxy 
substitution. A notable exception is in the case of the 3-hydroxy-4-methoxy derivative. For 
these compounds, correlations between activity and KD values were not as strong as 
previously.
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Table 10 provides a summary of the effects of –F, -CF3 and –OCF3 substitutions of β-
methyl-β-nitrostyrene. The 4-fluoro derivative had the highest activity against E. coli, while 
the 2-fluoro derivative was also of good activity. The activity against the Gram positive 
bacteria and the fungus were all high except for 49a, where a –CF3 group was substituted 
at the 2-position. Further details can be found in section 2.8 
 
Table 10: MIC values (μg/mL) of β-methyl-β-nitrostyrenes with fluorine-containing 
substitutions 
Compound Substitution KD E. coli S. aureus B. subtilis E. faecalis C. albicans 
12a 2-fluoro 138 42 3 3 5 3 
12b 3-fluoro 14 256 8 16 16 8 
12c 4-fluoro 101 27 2 2 2 2 
12d 2,4-difluoro 65 45 4 2 6 3 
49a 2-CF3 60 512 16 32 64 32 
49b 3-CF3 30 256 16 8 16 8 
49c 4-CF3 68 96 2 2 4 4 
50a 3-OCF3 18 256 16 8 16 8 
50b 4-OCF3 155 512 2 4 8 4 
 
  
2.10.3 The optimal KD values for activity of β-methyl-β-nitrostyrene 
derivatives 
In this project lipophilicity was used as a guide to identify the optimal KD values of tested 
compounds against the chosen bacteria. The results (Table 11), showed that the lower KD 
values for fluorinated compounds normally are effective against Gram positive bacteria 
and fungus. However, only 12c gave the best result against the Gram negative bacterium 
E. coli. Conversely, the Log P range for non-fluorinated compounds was very broad 
against the Gram positive and fungus. For E. coli the range has been narrowed 
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significantly, possibly due to the structure of each compound being similar to the β-methyl-
β-nitrostyrene derivatives. With this we discovered that the lipophilicity of β-methyl-β-
nitrostyrene derivatives is not the dominant factor affecting the potency against the 
chosen bacteria. The structure activity relationships (SARs) would still indicate the major 
factors that affects the potency. 
 
Table 11: The range of optimal KD values for activity of β-methyl-β-nitrostyrene derivatives 
Microorganism Non-fluorinated compounds Fluorinated compounds 
 
Effective KD 
range (MIC ≤ 16) 
Log P range 
Effective KD 
range (MIC ≤ 16) 
Log P range 
E. faecalis 70-2561 1.85-3.41 14-155 1.15-2.19 
S. aureus 41-2561 1.61-3.41 14-155 1.15-2.19 
B. subtilis 111-2561 2.05-3.41 18-155 1.26-2.19 
E. coli 111-479 2.05-2.68 101 2.00 
C. albicans 14-2561 1.15-3.41 45-138 1.81-2.14 
 
2.11 Trends with Gram positive bacteria  
The correlations between MIC and KD values were not straightforward with the Gram 
positive bacteria, but generally large KD values were associated with higher activity 
against these microorganisms. This was in contrast to KD values of compounds tested 
against E. coli, where lower KD values were required for high activity. The trends of results 
in detail are as follows. 
 
2.11.1 Trends with E. faecalis 
There was no correlation between MIC values and KD values for E. faecalis, even when 
the compounds were grouped as fluorine-containing and non-fluorine containing types. 
The r2 values were 0.0624 and 0.0261 respectively. However, it was apparent that for 
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each group (excluding those compounds that were not based on β-nitrostyrene alone) the 
KD values were higher (mean = 530) for the most active (MIC 2 – 6) compounds. For 
those compounds with less activity (MIC ≧ 8) the mean KD was 229. 
 
The compounds with high activity, despite low KD values (< 70) was 49c (-CF3 at position 
4), 12d (2 fluorine atoms at position 2 and 4), 12a (fluorine at 2 position) were partly due 
to the influence of fluorine substitution on activity and KD. All other compounds with high 
activity had KD values of ≧ 150. However, the poorest activity (MIC 64) was observed 
with compound 1a, without the β-methyl group and the same result was obtained with 1b, 
with no β-methyl group. Despite fluorine substitutions, compound 12c with KD 101 and 
MIC 16, was not among the best performers and had about the same activity as the 
unsubstituted β-methyl-β-nitrostyrene with KD 113. Generally, substitution with fluorine 
reduced the KD values but the extent of this reduction depended upon the position of 
substitution. For example in compounds 12a, 12b and 12c, substitution at position 3 gave 
the lowest KD of 14. However, the highest activity was seen in compound 12a (position 2 
substitution) with MIC 5 and KD 139 (the highest KD of the three). 
 
The difference between –CF3 and –CH3 was seen with compounds 49c and 52 both with 
substitution at the 4 position. The –CF3 substituted compound was highly active with MIC 
4 compared with MIC 32. Substitution of –CF3 at position 2 [49a] resulted in a compound 
of low activity (MIC 45). With –OCF3 substitution, compound 50b (position 4) with KD 155 
and MIC 8 was not quite as active as the methoxy compound with KD 479 and MIC 4. The 
best results of all were with compound 51 with two nitro groups having KD 556 and MIC of 
only 2. 
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2.11.2 Trends with S. aureus 
For –OH and –OCH3 substitution, the most active compounds against S. aureus were the 
4-hydroxy [8b] substituted compounds of β-methyl-β-nitrostyrene together with the 3,4-
dithydroxy [8c], 4-methoxy [9a] and the 3,4-dimethoxy [9b] derivatives. All of these 
compounds were more active than the unsubstituted parent compound but there was no 
significant correlation between the MIC and KD values. Substitution at the 3-position 
(compound 8a) was not as effective as substitution of –OH at the 4-position and was of no 
advantage over the unsubstituted compound. For all non-fluorine substitutions, the only 
compound of comparable activity to those above was compound 53b, the 2-naphthyl 
derivative with KD 2561 and MIC 4. For the fluorine-containing compounds, the most 
active were 12d (2,4-difluoro), 49c (4-trifluoromethyl) and 50b (4-trifluoromethoxy), closely 
followed by 12a (2-fluoro). However, no correlation between KD and MIC values was 
observed. The worst result was with 1b, the 4-fluoro-compound without β-methyl 
substitution. 
 
2.11.3 Trends with B. subtilis 
For –OH and –OCH3 substitution, the 3,4-dimethoxy derivative, with the highest KD of 250 
was the most active compound. Also of high activity were 8a (3-hydroxy) and 8c (3,4-
dihydroxy). For all the non-fluorine containing substitutions the results were similar to 
those of S. aureus, with 53b (2-naphthyl derivative) again showing high activity. For the 
fluorine-containing derivatives, the results were very similar to those for S .aureus, the 
worst result being with 1b (4-fluoro derivative but without β-methyl substitution), as it was 
with S. aureus. 
 
In summary, the results for the Gram positive bacteria are quite different from those with 
the Gram negative bacterium, E. coli, and indicate that high KD values are more likely to 
be preferable to low KD values for optimal activity. An example of this is the 2-naphthyl 
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derivative, (compound 53b, KD 2561) which is highly active against all these of the Gram 
positive bacteria (MIC 4) yet is inactive against E. coli (MIC > 512). Compound 12c is 
highly active against E. coli, but is not among the highest activities against any of the 
Gram positive bacteria. 
 
Compounds 8b, 9a, 9b, 12a, 12d and 53b are compounds that are highly active against 
all Gram positive bacteria tested. Compounds 12a, 12d and 49c are the fluorine 
derivatives that are highly active against these bacteria. 
 
2.12 Trends with Fungus 
2.12.1 Trends with C. albicans 
For –OH and –OCH3 substitution, the most active compounds were again the 3,4-
dimethoxy and 3,4-dihydroxy derivatives, as was the case for the Gram positive 
microorganisms. Both showed greater activity than the unsubstituted compound [11]. 
Importantly, the worst compounds were 10a and 10b with MICs of 128, yet each of these 
compounds had one methoxy group and one hydroxy group. The compound without β-
methyl group (1a) had less activity than compound 11, but was superior to compounds 
10a and 10b. For all non-fluorine substitutions, many of the compounds performed well 
with MIC values of 4. The outstanding compounds (because of poor activity, MIC 128) 
were 10a and 10b as mentioned previously (see last paragraph) 1a without the β-methyl 
group (MIC 32) and a nitrochromene (compound 54a) with MIC 64.There was no 
significant correlation between MIC and KD values. For all fluorine-containing compounds, 
the two of highest activity were compound 12a (2-fluoro derivative) and 12d (2,4-difluoro 
derivative). Fluorination of the nitrochromene made little improvement (54b compared with 
54a). Comparison of different positions of the fluorine atom indicated that position 2 may 
result in better activity than at positions 3 and 4. With regard to the –CF3 group, 
substitution at position 4 appeared to be the most favorable for activity (MIC 4). The –
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OCF3 group at position 4 gave a product with MIC 2, but this was little different to an –
OCH3 group (MIC 4). The best –fluoro, -trifuoromethyl and –trifluoromethoxy substitutions 
proved to be more active than the one without substitution [11]. No significant correlation 
was obtained between MIC and KD values. 
 
In summary, the results for the fungus, C. albicans, are similar to those for the Gram 
positive bacteria. However, the following points of difference were observed. Compound 
8c (3,4-dihydroxy derivative) was highly active against C. albicans, and also highly active 
against S. aureus, but had less activity against B. subtilis. Otherwise, all of the 
compounds which were highly active against the Gram positive bacteria were also highly 
active against C. albicans. 
 
2.13 Mechanism of action 
One possible mechansim for activity of these compounds was suggested by Park and 
Pei16 who showed that β-nitro-ethenyl benzene (β-nitrostyrene) is a reversible inhibitor of 
the tyrosine phosphatases PTP1B by means of the formation of a covalent complex with 
cysteine at the catalytic site. In the absence of free thiol they pictured the selective 
nucleophilic attack by cysteine on the nitrogroup of β-nitro-ethenyl benzene as the 
following: 
 
 
 
 
 
Their mechanistic studies provided the basis for their reasoning. The rationale proposed 
was that the positive charge on the nitrogen atom, should be particularly reactive to 
nucleophilic attack, forming a reversible adduct that inhibited PTP1B. However, exactly 
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the opposite is found in the literature. The conjugate addition to nitroalkenes reflects the 
high reactivity of nitroalkenes towards nucleophilies169, 170 and it is widely recognized that 
nitro group olefins undergo rapid conjugate addition with thiol-type nucleophiles171-174. A 
literature search on the reaction of thiols with nitroarenes found the investigation by Hwu 
and co-workers175 who reported that at 185°C for 24hr CH3SiSNa was able to reduce 
various aromatic nitro compounds to amines. The susceptibility of the double bond to act 
as a highly active Michael acceptor for the cysteine nucleophile is for greater than the 
selective of direct nucleopholic reaction with the nitro group. It is proposed that the 
following mechanisms could apply176. However it does not account for the greater 
antibacterial potencies of the β-methyl-β-nitrostyrene compounds. 
 
 
 
 
 
 
 
 
 
The difference between the cell wall of the Gram positive and Gram negative bacteria is 
that Gram negative bacteria have an extra layer called the lipopolysaccharide layer1, 4-6, 9. 
The reason why high lipophilicity compounds (e.g. 53b) can not penetrate into a Gram 
negative bacterium like E. coli is because this high density lipopolysaccharide act as an 
effective barrier to prevent highly lipophilic agents penetrating the membrane to the 
interior of the cell6, 9. This is a possible rationale why compounds like 53b work effectively 
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against the Gram positive bacteria as they do not have this layer and high lipophilicity 
compounds and are able to penetrate the cell walls of these bacteria. 
 
2.14 Conclusions 
The performance of β-nitrostyrene derivatives is governed by the type of substitution on 
the aromatic ring, as well as by the length of the side chain. According to the tests 
performed the following conclusions could be drawn: 
1. β-nitrostyrene has antibacterial and antifungal activity, but activity against E. coli is 
unsatisfactory. 
2. β-methyl-β-nitrostyrene is superior to β-nitrostyrene, showing greater activity to all 
the microorganisms except S. aureus. The β-methyl group confers optimum 
activity, but a further increase in the size of the side chain results in lower activity. 
3. Compound [7], with a methylene dioxy ring bridging positions 3- and 4- on the 
aromatic ring with commercial potential, BDM-I (Biodiem Pty Ltd), showed high 
activity against the Gram positive bacteria and fungus (C. albicans) but was 
unsatisfactory against E. coli. 
4. Further experiments to investigate the value of substitutions on the aromatic ring 
with fluorine and fluorine-containing groups such as –CF3 and –OCF3 indicated 
that fluorine substitution at the 4-position provided the most active derivative 
(compound 12c). A general improvement in activity was noted compared with β-
methyl-β-nitrostyrene (parent compound). 
5. The substitution on the aromatic ring of β-methyl-β-nitrostyrene by hydroxy and 
methoxy groups produced many compounds with high activity against the Gram 
positive bacteria and C. albicans. However, many of these did not have high 
activity against E. coli. Compounds with comparable activity to the 4-fluoro 
compound [12c] across the range of microorganisms tested were the 4-methoxy 
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[9a] and 3,4-dimethoxy [9b] derivatives. Combinations of hydroxy and methoxy 
were not quite as effective and the positions of substitution were important factors. 
6. Compound 53b, featuring a naphthalene substitution was interesting in that it gave 
excellent results against all the Gram positive bacteria and C. albicans, but failed 
badly against E. coli. It had a high KD value (2561), which seems to be desirable 
for activity against Gram positive bacteria. 
7. Compounds with lowest KD values appear to be more effective against E. coli than 
those with high KD values and high degrees of correlation were obtained in most 
cases. 
8. Other compounds which performed well against Gram positive bacteria and C. 
albicans was compound 51, with two nitropropenyl groups. However, it was 
completely ineffective against E. coli. 
9. Other fluorine derivatives which also performed well against Gram positive bacteria 
and C. albicans were compound 49c with substitution of –CF3 at position 4 and 
compound 50b, with substitution of –OCF3 at the same position. The latter 
compound was completely ineffective against E. coli. 
10. The requirements for high activity against E. coli are vastly different from those 
against the Gram positive bacteria. Differences are also seen with C. albicans, but 
the results against this fungus are much closer to those against the Gram positive 
bacteria than the E. coli. 
 
Compounds that were not simple derivatives of β-methyl-β-nitrostyrene, i.e. compounds, 
51, 54a, 54b were of interest, but only compound 51 was in the higher activity bracket. 
The compound with two nitropropenyl groups is extremely interesting as it had high 
activity against all microorganisms tested except E. coli. It had a KD of 556, again 
reinforcing the view that higher KD values are often associated with higher activity against 
the Gram positive bacteria. Further work will evaluate compounds with other type of 
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structures such as β-lactams, macrolides, and so on… Therefore it will then be possible to 
compare the β-nitro arenes with the antibiotics already in use. 
 
2.15 E/Z configurations of the tested compounds 
The E and Z configurations of a compound is always important in Medicinal Chemistry as 
either of them can be the key conformation to enhance the drugs efficiency. Most of the 
compounds in this project are based on β-methyl-β-nitrostyrene except 1a, 1b, 55a and 
55b.  
 
 
 
The definition of E and Z configurations depends upon the assignment of priorities to 
double bond substituents based on Cahn-Ingold-Prelog, priority rules177. For example 
consider an alkene which the two high-priority groups are on the opposite side of the 
double bond, the compound will be assigned as E configuration. The Z configuration is 
when high priority groups are on the same side of the double bond. According to the NMR 
obtained for each β-methyl-β-nitrostyrene derivatives the E configuration was the 
dominant conformation. The ratio of E to Z for example in 49c is 14:1 and the ratio of Z 
configuration would decrease after recrystallization, as the Z compound is more soluble in 
the solvent (95% alcohol). However, an exceptional case was obtained in 49a where the Z 
configuration is the dominant structure (approx. 1:1.8). As 49a existed as a liquid, 
recrystallization can not apply to this compound to minimize the ratio between the E/Z 
configurations unless submitting the sample to other analytical instruments (e.g. HPLC) to 
separate the two isomers. According to the structure of most of the major compounds, the 
E configuration domination is due to two high-priority groups, which are the phenol and 
nitro group (take 49c as an example), are on the opposite side of the double bond except 
in 49a. 
R
NO2
(E)--methyl--nitrostyrene
R
NO2
(Z)--methyl--nitrostyrene
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2.16 Substrate for nitrostyrene formation via Henry reaction 
protocol 
Two compounds that have been synthesized, but not yet been tested were 1c and 56b 
(See Chapter 3). They certainly can be tested in the future; however, the aim for making 
them is they are precursors for future synthesis of other novel nitrostyrene compounds. 
 
2.17 Future work  
There are some compounds that should be investigated for biological testing. Some of 
them are fluorinated compounds, some of them are the novel compounds and some of 
them would be designed to compare their biological activity with the existing compounds. 
(Compounds with * indicates new substances) 
 
2.17.1 The fluorinated compounds 
 
 
 
 
Additionally 19e should be made for biological evaluation. Compound 50c* could be used 
to complete the comparison of antimicrobial activity with substitution series of –F, -CF3 
and -OCF3. 
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Compound 58* and 62* could be used to test whether replacing the proton by fluorine 
atom(s) would still affect the biological activity. 
 
2.17.2 Chain extension compounds 
 
 
 
These two chain extended compounds can be used to prove the chain length of the 
parent compounds are the ideal length for biological activity supporting Milhazes et al.22 
theory. 
 
2.17.3 New compounds for comparison purposes 
NO2
62*  
Although a similar compound to the above structure has been made before, such a 
compound with saturated six- membered ring needs to be tested. 
 
2.17.4 Existing compounds for comparison purposes 
 
These known compounds can be found in the literature and again obvious results could 
be seen from them and we can use them to show that β-methyl-β-nitrostyrene derivatives 
are one of the most effective types of antibacterial agents. 
 
NO2
58a
NO2
58b
65a 65b
NO2
64
NO2
O2N
63
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Chapter 3 
 
3 Experimental 
 
3.1 General Methods and Conditions 
3.1.1 Octanol-water Partition Coefficients 
The lipophilicity level of each compound was determined by octanol-water partition 
coefficients. The buffer solution used in the determination of KD was made by mixing 
sodium chloride (3.78g, 65mmol), disodium hydrogen orthophosphate (2.14g, 18mmol) 
and sodium dihydrogen orthophosphate (0.78g, 5.5mmol) in 500mL water at room 
temperature (~22°C) and had a pH of 7.5. Each compound (10mg) was dissolved in 
octanol (2mL) in a stoppered test tube, followed with the addition of the buffer solution 
(2mL) and the tube was shaken over 48 hours and finally the mixtures were allowed to 
separate into two layers. The top layers were removed and absorbance measured after 
dilution 1:20, 1:50 or 1:200 to 3mL with octanol in a 1 cm path length apart cuvette at 
370nm for each diluted sample. The aqueous bottom layers were removed and the 
absorbance measured without dilution.  
 
KD measurements were according to the equation: 
KD
[Octanol]
[Water]
=
 
As the absorbance of the octanol and water layers is directly proportional to the 
concentration in each layer, the KD value can be calculated from the relative absorbance 
of each layer.  
The calculated log P values (C log P) were obtained using Marvin Sketch (ChemAxon); 
and a table of all structures with measured and calculated log P values can be referred in 
Appendix section. 
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3.1.2 Analysis and instruments 
Gas Chromatography and Mass Spectroscopy (GC/MS) spectra were obtained in 
either electron ionization (EI) or positive/negative electrospray (ESI) modes with the 
Varian Saturn 2200 GC/MS/MS (ion-trap) coupled to a Varian CP-3800 GC (FactorFour – 
Capillary Column; Stationary Phase: VF-5ms; L(m) ID(mm) x OD (mm): 30 x 0.25 x 0.39) 
or Micromass Platform II ESI/MS (240 V, 10 A).  
 
Melting points of the products were determined on a Gallenkamp melting point apparatus 
and are not corrected. 
 
1H and 13C NMR spectra were determined using a Bruker Advance 300 MHz or Bruker 
Avance 300 III MHz spectrometer. All spectra were obtained and interpreted using 
TopSpin v2.0. Some FIDs from Bruker Advance 300 MHz were processed using 
Mestrec23. All samples, except 8b which was dissolved in DMSO, were dissolved CDCl3. 
Proton (1H) chemical shifts were recorded as δ values in parts per million (ppm) downfield 
shifts; the reference peak is a singlet at 2.78 ppm for DMSO and singlet at 7.26 for CDCl3. 
Chemicals shifts are presented in multiplicity, coupling constant(s) (J in Hz), integration 
and assignments. Abbreviations are: s = singlet, d = doublet, t = triplet, q = quartet, p = 
pentet, dd = doublet of doublet, m = multiplet. Carbon (13C) chemical shifts were 1H 
decoupled, and recorded as δ values in parts per million (ppm). Reference peak for 
DMSO is a massive multiplet at 40.0 ppm and triplet at 77.0 for CDCl3. Additional 
information to assist assignments of peaks are from CH COSY spectra, gCOSY, DEPT 
45, 90, 135, HMBC and HSQC. 
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3.2 Materials 
Organic reagents, solvents and purification reagents were purchased from Ajax Finechem 
Pty Ltd, BDH, Chem Supply, Merck and Sigma Aldrich and all were of AR quality or better 
than 99% purity. Results of compounds 7, 8a, 8b, 10a and 10b were from Nicoletti et al.29 
and for comparison and completeness. Compounds 7, 8b, 8c, 9a, and 10b were prepared 
by HIGH FORCE Research Ltd U.K. 
 
Microbial stocks 
The strains used for biological tests were: Staphylococcus aureus ATCC 29213, Bacillus 
subtilis ATCC 6633, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922 
and Candida albicans ATCC 10231. The microbial stocks were kept under -80°C in MHB 
(Oxoid, Cambridge, UK). The antibiotics used as a control for biological testing were 
erythromycin, tetracycline (Sigma Aldrich, St-Louis, Mo, USA) and ciprofloxacin (MP 
Biomedicals, Irvine, CA, USA). The nitrostyrene derivatives were diluted and stored in the 
dark room at room temperature for a month and maintained inhibitory potency when 
assayed by measurement of the MIC in bacterial species. 
 
3.3 Minimum inhibitory concentrations 
The microbiology testing and dilution was based on the National Committee for Clinical 
Laboratory Standards methods in MHB (Oxoid) for bacteria or Sabouraud Liquid Medium 
(SLM, Oxiod) for the fungus. C. albicans. Microplates assays were performed in clear, 
round-bottomed, 96-well plates (Sarstedt Australia, SA, AUS) with a total volume of 200 
μL per well. The densities of inoculums were estimated by suspension turbidity using 
McF0.5 standard. Standard inoculums densities for bacteria were approximately 1 x 105 
Colony Forming Units per mL (CFU/mL) and 1 x 104 CFU/mL for C. albicans7. 
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Inoculum densities were confirmed by serial dilution plating onto NA and incubation 
aerobically at 37°C for 24 hrs. The tested nitrostyrene derivatives were added to plates at 
two times tested concentrations in 100 μL media. Ciprofloxacin was used as an internal 
positive control for bacterium and Miconazole for C. albicans. Microplates were incubated 
18-24 hrs at 37°C aerobically before reading wells visually for turbidity. All assays 
included duplicated wells and were at least twice replicated. The geometric MIC (μg/mL) 
for each strain was adjusted to the nearest log2 dilution tested. MIC results were reported 
as MIC (μg/mL) for standards. 
 
3.4 Synthesis of nitroprop-1-enyl-benzene series 
The standard Henry reaction has been used as Method A and B as well as other methods 
from previous work29. Each method had a different reaction time as well as having used 
different reagents in the reaction, but nitroethane was common to all, except for β-
nitrostyrene, where nitromethane was used. 
 
Standard Henry Reaction (Method A) 
The first method used was by Knoevenagel166 where condensation was carried at room 
temperature in the presence of aliphatic amines such as methylamine. The reaction time 
required was much longer than for Method B, but no heating was required. Overall yield 
was often lower than from Method B, therefore most of the compounds were synthesized 
using Method B. Method B was based on Gairaud and Lappin’s178 method of making 
nitrostyrene compounds. 
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3.4.1 Synthesis of β-Nitrostyrene 
β-Nitrostyrene/2-nitroeth-1-enylbenzene [1a] 
NO2
1a
CHO
CH3NO2
CH3COONH4, reflux
  
The synthesis procedure was based on Black et al.179. Benzaldehyde (1.04g, 9.8mmol) 
was added to a stirring solution containing ammonium acetate (0.20g, 2.6mmol) and 
nitromethane (5.68g, 93.44mmol). The mixture was heated at reflux (90°C) for 6 hours, 
poured to water (100mL) and extracted with diethyl ether (3 x 30mL). The organic extract 
was washed with saturated brine solution (25%, 100mL), dried over magnesium sulphate 
(MgSO4), filtered and concentrated under high vacuum. The residue was purified by 
recrystallization from ethanol (95%) to give yellow needles of compound 1a with a yield of 
82% and melting point 58-59°C (Lit. 58-59°C)179 
1H NMR (300 MHz, CDCl3): δH (ppm): 7.96-7.91 (d, J = 13.7 Hz, 1H, C=αC-H), 7.54-7.49 
(d, J = 13.7 Hz, 1H, C=βC-H), 7.43-7.38 (m, 5H, Ar-H).  
13C NMR (75 MHz, CDCl3): δC (ppm): 139.1 (C=C, α carbon), 137.1 (Ar), 132.2 (C=C, β 
carbon), 130.1 (Ar), 129.4 (Ar), 127.1 (Ar). 
 GC/MS m/z (M+) 149. 
 
4-Fluoro-β-nitrostyrene [1b] 
NO2
1b
F
 
The synthesis method used was that by Côté et al.180 which was modified from Andrey et 
al.181. A stirred solution of acetic acid (33.5mL) and ammonium acetate (4.4g, 57.1mmol) 
was added to nitromethane (10g, 164.0mmol) followed by 4-fluorobenzaldehyde (2.94g, 
23.7mmol) and the solution was refluxed in an oil bath at 100°C for 5hours and 30 
minutes. The dark orange mixture was then cooled to room temperature and poured into 
water (100mL). The pH of the mixture was then regulated to 7 using adding sodium 
hydroxide solution (2M), after which the product was extracted with ethyl acetate (3 x 
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100mL). The combined organic extracts were dried over MgSO4 then filtered and 
concentrated under high vacuum. Further purification was done by recrystallizing the 
compound from 95% ethanol to remove the brown oily impurities, resulting in obtaining 
pale yellow needles with yield 57%, and melting point 99-100°C (Lit. 98-100°C)182. 
1H NMR (300 MHz, CDCl3): δH (ppm): 7.94-7.89 (d, J = 13.8 Hz, 1H, αC-H), 7.52-7.44 (m, 
multiplet occurred due to the peaks have overlapped with peaks in the ring, 1H, βC-H), 
7.52-7.44 (m, multiplet occurred due to the peaks have overlapped with peaks in the β 
carbon, 2H, Ar-H), 7.11-7.05 (t, J = 8.4, 2H, Ar-H).  
13C NMR (75 MHz, CDCl3): δC (ppm): 164.9 (d, J = 255.1 Hz, C-F), 137.8 (C=C, β carbon), 
136.8 (C=C, α carbon), 131.2 (Ar), 126.3 (Ar), 116.7 (Ar). 
GC/MS m/z (M+) 167.  
 
3.4.2 Synthesis of β-methyl- β-nitrostyrene 
2-Nitroprop-1-enyl benzene [11] 
NO2CHO
NO2
11
+
Na2CO3, CH2NH2.HCl
KOH in ethanol, EtOH
Room temperature
 
The synthesis of this compound was performed by Professor Hugh Cornell who used 
Method A. To benzaldehyde (2.12g, 20mmol), was added nitroethane (1.8g, 24mmol), 
anhydrous sodium carbonate (0.3g, 3mmol), methylamine hydrochloride (0.15g, 2.2mmol) 
with potassium hydroxide (0.05g, 0.9mmol, dissolved in 1.0 mL ethanol) and 2.5mL 
ethanol. The mixture was reacted at room temperature with sufficient stirring for 44 hours. 
After that, the mixture was dissolved in hot ethanol (95%) and the hot solution decanted 
and cooled to 5°C for 2 hours. The dried crude product was filtered and air dried to give 
yellow crystals produced with yield 22% and melting point from 60-62°C. The crude 
product was then recrystallized from 3mL ethanol (95%), washed with 2 x 0.5 portions of 
chilled ethanol. Purified yellow crystals were obtained in 9% yield with melting point 63-
64°C (Lit. 64°C)183. 
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1H NMR (300 MHz, CDCl3): δH (ppm): 8.10 (s, 1H, H-C=C), 7.46 (s, 5H, Ar-H), 2.47 (s, 3H, 
CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 147.7 (C=C, β carbon), 133.5 (C=C, α carbon), 
132.4 (s, C=C-C in Ar), 129.9 (Ar), 129.7 (Ar), 128.9 (Ar), 14.0 (CH3).  
GC/MS m/z (M+) 149.  
 
3.4.3 Synthesis of monofluoro substitution product of β-methyl-β-
nitrostyrene 
1-Fluoro-2-(nitroprop-1-enyl) benzene [12a] 
F
CHO
F
NO2NO2
CH3COONH4, CH3COOH
Reflux 12a  
Method B was used for this reaction. 2-Fluoro-benzaldehyde (4.81g, 38.8mmol) was 
dissolved in nitroethane (4.01g, 53.5mmol, 20% excess), ammonium acetate (4.00g, 
52mmol) and glacial acetic acid (5mL) were added and the mixture was refluxed for 2 
hours in an oil bath at 100°C. The orange coloured mixture was then chilled and de-
ionized water (6mL) was then added. A small portion of the crude orange crystalline 
product obtained by filtration was taken for determination of melting point. The rest of the 
product was dissolved in hot ethanol (95%, 2ml) and chilled for an hour to obtain the 
recrystallized product. The recrystallization process was repeated and light yellow crystals 
were obtained (Compound 12a; 2.38g, 34% of theoretical yield). Melting points were 1st 
crude: 42- 43°C, 2nd crude: 43- 44°C and final product 45-47°C.  
1H NMR (300 MHz, CDCl3): δH (ppm): 7.98 (s, 1H, H-C=C), 7.39-7.33 (t, J = 8.7 Hz, 1H, 
Ar-H), 7.19 (d, J = 8.7 Hz, 1H, Ar-H), 7.12 (d, J = 8.6 Hz, 1H, Ar-H), 7.04 (d, J = 8.8 Hz, 
1H, Ar-H), 2.36 (s. 3H,C-H, E), 1.59 (s, 3H, C-H, Z).  
13C NMR (75 MHz, CDCl3): δC (ppm): 165.1 (d, J = 252.2 Hz, C-F), 147.5 (C=C, β carbon), 
132.5 (C=C, α carbon), 132.2 (Ar), 132.0 (Ar), 128.7 (Ar), 116.4 (Ar), 116.2 (Ar), 14.0 
(CH3); GC/MS m/z (M+) 181.  
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Similar procedures were repeated as described above to obtain compounds. 12c, 12d, 
53a and 53b. 
 
1-Fluoro-3-(nitroprop-1-enyl) benzene [12b] 
F NO2
12b  
This compound was prepared with a method similar to of Werbal, L. M. et al.184 by 
reacting 3-fluorobenzaldehyde (1g, 8.05mmol) with ammonium acetate (0.19g, 2.4mmol) 
in nitroethane (4.98g, 66.4mmol), under reflux overnight (approximately 17 hours) in an oil 
bath at 125°C. The compound was identified by thin layer chromatography (TLC). The 
mixture was then concentrated under high vacuum to remove the excess nitroethane and 
then the yellow mixture was dissolved in chloroform (20ml), washed with water (3 x 20mL) 
and with sodium chloride solution (25%, 20mL). The mixture was dried (MgSO4) and 
concentrated under high vacuum. A yellow liquid was obtained (0.75g) this being 52% of 
theoretical yield.  
1H NMR (300 MHz, CDCl3): δH (ppm): 8.04 (s, 1H, C=C-H), 7.46-7.39 (m, multiplet due to 
proton peaks in the ring coupled with other peaks in the ring, 1H, Ar-H), 7.46-7.39 (m, 
multiplet due to proton peaks in the ring overlapped with other peaks in the ring and with a 
F atom, 1H, Ar-H), 7.22-7.19 (d, J = 7.8 Hz, 1H, Ar-H), 7.13-7.09 (d, J = 9.3 Hz, 1H, Ar-H 
coupled with F), 2.42 (s, 3H, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 164.3 (d, J = 246.8 Hz, 1C, C-F), 148.7 (C=C, β 
carbon), 134.6 (Ar), 132.0 (Ar), 130.6 (C=C, α carbon), 130.5 (Ar), 125.9 (Ar), 125.7 (Ar), 
13.9 (CH3).  
GC/MS m/z (M+) 181. 
Similar procedures were repeated as described above to obtain compounds: 12e, 49a, 
49b, 50a and 50b. 
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1-Fluoro-4-(nitroprop-1-enyl) benzene [12c] 
NO2
12c
F  
The product was obtained as yellow crystals with 30% of theoretical (2.13g). Melting 
points: 1st crude: 38°C, 2nd crude: 45°C and final product: 65-66°C154. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.06 (s, 1H, H-C=C), 7.46 (dd, J = 3.3, 5.4 Hz, 2H, 
Ar-H), 7.17 (t, J = 8.7 Hz, 2H, Ar-H), 2.46 (s, 3H, C-H, E), 1.59 (s, 3H, C-H, Z).  
13C NMR (75 MHz, CDCl3): δC (ppm): 165.2 (d, J = 252.2 Hz, 1C, C-F), 147.5 (C=C, β 
carbon), 132.5 (C=C, α carbon), 132.2 (Ar), 128.5 (Ar), 128.5 (Ar), 116.3 (Ar), 116.0 (Ar), 
14.0 (CH3)  
GC/MS m/z (M+) 181.  
 
1,3-Difluoro-4-(nitroprop-1-enyl) benzene [12d] 
F
NO2
F
12d  
This compound was prepared by the same method as 12d (Method B) making use of the 
Henry reaction. Quantities of chemicals used were: 2,4-difluorobenzaldehyde (0.78g, 
5.4mmol), nitroethane (0.46g, 5.2mmol, 20% excess), ammonium acetate (0.80g, 
10.0mmol and glacial acetic acid (1mL). The mixture was refluxed as before for 2 hours in 
an oil bath at 100°C. 12d was obtained as yellow crystals with a melting point of 48-49°C 
(0.47g, 43% of theoretical yield). 1H NMR (300 MHz, CDCl3): δH (ppm): 8.06 (s, 1H, C=C-
H), 7.45 – 7.35 (dd, J = 8.3, 8.4Hz, coupling due to two fluorine atoms were coupling with 
this proton. 1H, Ar-H); 7.04 – 6.96 (dd, for the proton at the middle of two fluorine atoms it 
should split to a quartet as two fluorine atoms were coupling with it. J = 8.5, 8.5 Hz. 1H Ar-
H. The other proton at position 6 should be a triplet as there is only fluorine atom coupling 
with it. t, J = 8.5 Hz, 1H, Ar-H), 2.38 (s 3H, CH3, E), 1.57 (s 3H, CH3, Z).  
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13C NMR (75 MHz, CDCl3): δC (ppm): 163 – 162.3 (quartet due to two fluorine atoms 
coupling with the carbon. J = 222.1, 233.6Hz. 1C, F-C=C-C-F), 162.2 – 159 (q, J = 
234,4Hz. 1C, F-C=C-C-F), 149.5 (s, C=C α carbon), 134.1 – 131.1 (quartet due to two 
fluorine atoms coupling with the carbon. J = 234.6 Hz, 1C, F-C-C=C-C=C-F), 125.7 – 
125.4 (s, C=C, β carbon), 117.0 – 116.5 (d, J = 9.9Hz, 1C, F-C=C), 112.3 – 111.7 (q, J = 
3.6, 21.7, 24.9Hz, 1C, F-C-=C-C-F), 104.8 – 104.4 (d, J = 25.8, 1C, F-C-C=C), 14.2 – 14.0 
(CH3).  
GC/MS m/z (M+) 199. 
 
Pentafluoro-2-(nitroprop-1-enyl) benzene [12e] 
NO2
12e
F
F
F
F
F
 
The scale of chemicals used in the reaction was 1/50 to what Werbal, L. M. et al.184 used. 
A mixture of pentafluorobenzaldehyde (1g, 5.1mmol) and ammonium acetate (0.12g, 
1.53mmol) in nitroethane (3.15g, 42mmol) was heated (120°C) under reflux for 17 hours. 
The large excess of nitroethane was removed under high vacuum. The residue was 
dissolved in chloroform (10mL) and the mixture was then washed with water (4 x 20mL) 
and with saturated brine solution (25%, 2 x 20mL). The chloroform solution was dried over 
MgSO4, filtered and concentrated under high vacuum. The product was purified by flash 
column chromatography on silica gel with 30% ethyl acetate in hexane (v/v) to obtain a 
yellow liquid in yield of 2.5%.  
GC/MS m/z (M+) 253; (the amount of compound was only enough for GC/MS 
characterization). 
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3.4.4 Synthesis of trifluoromethyl substitution of β-nitrostyrene 
1-Trifluoromethyl-4-(nitroprop-1-enyl) benzene [49c]  
NO2
F3C 49c  
Compound 49c was synthesized by a method similar to that of Bergner and Opatz185. 4-
Trifluoromethylbenzaldehyde (1g, 5.7mmol) and ammonium acetate (0.38g, 5.0mmol) 
were dissolved in nitroethane (20mL, 280mmol), heated to 100°C and refluxed overnight. 
The excess nitroethane was removed under high vacuum and the yellow coloured mixture 
was poured into water (20mL) and extracted with ethyl acetate (3 x 20mL). The combined 
organic extracts were washed with water (3 x 20mL) and sodium chloride solution (25%, 
20mL) and then dried over anhydrous MgSO4. The solvent was removed under high 
vacuum (enhanced with liquid nitrogen) to yield a yellow solid (1.16g, 87% yield). The 
material was purified by washing with cold ethanol (95%) to yield 49c (0.748g, 42%), a 
yellow solid which had a melting point of 96-98°C (Lit. 36-38.5°C)186. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.02 (s, 1H, C=C-H), 7.65 (d, J = 8.3 Hz, 2H, Ar-H), 
7.46 (d, J = 8.2 Hz, 2H, Ar-H), 2.37 (s, 3H, C-H, E), 1.59 (s, 3H, C-H, Z).  
13C NMR (75 MHz, CDCl3): δC (ppm): 148.9 (s, C=C, β carbon), 135.6 (Ar), 132.6 (s, C=C, 
α carbon), 131.4 (s, Ar-C-CF3), 129.8 (Ar), 128.5 (Ar), 123.7 (q. J = 273.6 Hz, CF3), 13.6 
(CH3).  
GC/MS m/z (M+) 231. 
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1-Trifluoromethyl-2-(nitroprop-1-enyl) benzene [49a] 
NO2
49a
CF3
 
The method of synthesis was similar to compound 12b. The quantities of chemicals used 
were: 2-trifluoromethylbenzaldehyde (1.0g, 5.7mmol), ammonium acetate (0.13g, 
1.7mmol) and nitroethane (3.52g, 47mmol) were refluxed as before for 19 hours in an oil 
bath at 125°C. The compound was purified by flash column chromatography on silica gel 
with hexane/ethyl acetate (20/1) to obtain a yellow liquid in a yield of 46%. For this 
compound the relative amount of the cis and trans isomers are 60% and 40% respectively. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.16 (s, 1H, C=C-H), 7.69-7.67 (d, J = 7.8 Hz, 1H, 
Ar-H, trans-compound), 7.61-7.53 (m, multiplets due to overlap of the cis and trans-
compounds, 1H, Ar-H), 7.48-7.42 (m, multiplets due to overlapped with the cis and trans-
compounds, 1H, Ar-H), 7.39-7.34 (t, J = 6.6 Hz, cis-compound, 1H, Ar-H), 7.28-7.26 (d, J 
= 7.5 Hz, cis-compound, 1H, Ar-H), 7.17-7.15 (d, J = 6.3 Hz, trans-compound, 1H, Ar-H), 
2.31 (s, trans-compound, 3H, CH3), 2.17 (s, cis-compound, 3H, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 149.9 (s, 1C, C=C, β carbon), 148.9 (Ar), 132.0 (Ar), 
130.2 (s, C=C, α carbon), 130.0 (cis Ar), 129.3 (Ar), 129.0 (trans Ar),128.4 (cis Ar),127.2 
(q, J = 264.5 Hz,1C, CF3), 126.4 (trans Ar), 125.9 (Ar), 124.7 (Ar), 122.0 (Ar), 19.3 (s, 1C, 
trans CH3), 13.7 (s, 1C, cis CH3).  
GC/MS m/z (M+) 231. 
 
1-Trifluoromethyl-3-(nitroprop-1-enyl) benzene [49b] 
NO2
49b
F3C
 
The quantities of chemicals used were the same as for compound 49a. However, the 
mixture was refluxed for 17 hours in an oil bath at 140°C. The compound was purified by 
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flash column chromatography on silica gel with hexane/ethyl acetate (20/1) to obtain a 
yellow liquid in a yield of 46%.  
1H NMR (300 MHz, CDCl3): δH (ppm): 8.07 (s, 1H, C=C-H), 7.44 - 4.38 (t, J = 8.7 Hz, 1H 
Ar-H), 7.27 (d, J = 7.9 Hz, 1H, Ar-H), 7.19 (d, overlapped with other peaks, 1H, Ar-H), 7.17 
(s, 1H, r-H), 2.34 (s, 3H, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 149.1 (s, C=C, β carbon), 133.3 (Ar), 132.8 (Ar), 
131.6 (Ar), 131.2 (Ar), 130.3 (Ar), 129.5 (Ar), 126.3 (s, C=C, α carbon), 123.6 (q, J = 272.4 
Hz, 1C, CF3), 13.8 (s, CH3).  
GC/MS m/z (M+) 231. 
 
3.4.5 Synthesis of trifluoromethoxy derivative of β-nitrostyrene 
1-Trifluoromethoxy-4-(nitroprop-1-enyl) benzene [50b] 
NO2
F3CO 50b  
Compound 50b was prepared using the same method as 12b. 4-
trifluoromethoxybenzaldehyde (1g, 5.3mmol), ammonium acetate (0.12g, 1.6mmol) and 
nitroethane (3.3g, 43.3mmol) were heated at 115°C for 5 hours. The yellow mixture was 
placed under high vacuum to remove excessive nitroethane and then dissolved in 
chloroform (10mL), washed with water (3 x 20mL) and washed again with saturated brine 
solution (25%, 2 x 20mL). The washed mixture was then dried over MgSO4, and then 
concentrated under high vacuum (liquid nitrogen assisted). Yellow crystals were obtained 
in yield of 73% with melting point 47-48°C.  
1H NMR (300 MHz, CDCl3): δH (ppm): 7.98 (s, 1H, C=C-H), 7.42 (d, J = 8.7 Hz, 2H, Ar-H), 
7.24 (d, J = 8.3 Hz, 2H, Ar-H), 2.37 (s, 3H, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 150.0 (s, O-C in Ar), 148.3 (s, C=C, β carbon), 
131.9 (s, C=C, α carbon), 131.5 (Ar), 130.9 (Ar), 121.1 (Ar), 120.3 (q, J = 258.2 Hz, 1C, 
CF3), 13.9 (s, CH3). 
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GC/MS m/z (M+) 247. 
 
1-Trifluoromethoxy-3-(nitroprop-1-enyl) benzene [50a] 
NO2
50a
F3CO
 
The quantities of chemicals used were the same as for compound 50b. In the case, the 
mixture was refluxed for 24 hours immersed in an oil bath at 100°C. The orange yellow 
mixture was then extracted with ethyl acetate (20mL) and the extract washed with sodium 
bicarbonate (NaHCO3) (3 x 20mL) and saturated brine solution (25%, 20mL). The mixture 
was dried over MgSO4 and concentrated under high vacuum (liquid nitrogen assisted). A 
yellow liquid was obtained in yield of 51%. For this compound the relative amount of the 
cis and trans isomers are 31% and 69% respectively. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.05 (s, 1H, C=C-H), 7.45-7.49 (t, J = 8.7 Hz, 1H, 
Ar-H, trans compound), 7.40-7.36 (t, J = 6.6 Hz, 1H, Ar-H, cis compound), 7.31-7.28 (d, J 
= 7.2 Hz, 1H, Ar-H, trans compound), 7.19-7.17 (d, J = 7.8 Hz, 1H, Ar-H, cis compound), 
6.49 (s, 1H, Ar-H)2.45 (s, 1H, CH3, trans compound), 2.38 (s, 1H, CH3, cis compound).  
13C NMR (75 MHz, CDCl3): δC (ppm): 149.3 (s, C-OCF3), 149.2 (s, C=C, β carbon), 134.4 
(Ar), 131.7 (s, C=C, α carbon), 130.4 (trans Ar), 130.0 (Ar), 128.1 (cis Ar), 126.2 (trans Ar), 
124.1 (Ar), 122.6 (q, J = 258.1 Hz, 1C, OCF3), 122.1 (Ar), 121.2 (trans Ar), 120.6 (cis Ar), 
19.9 (s, 1C, cis CH3), 13.9 (s, 1C, trans CH3).  
GC/MS m/z (M+) 247. 
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1-Methyl-4-(nitroprop-1-enyl) benzene [52] 
 
H3C
NO2
52  
Method B was used to synthesize this compound. 4-methyl-benzaldehyde (4.00g, 
33.3mmol) was dissolved in nitroethane (3.12g, 33.3mmol, 25% excess), ammonium 
acetate (5.13g, 66.6mmol) and glacial acetic acid (10mL) added and the mixture refluxed 
for 3 hours in an oil bath at 110°C. The green brown coloured mixture was then chilled 
and de-ionized water (15mL) was then added. The product was then dissolved in hot 
ethanol (95%, 2ml) and chilled for an hour to obtain the recrystallized product as light 
yellow crystals afterward Compound 52 (4.72g, 80% of theoretical yield). The melting 
point was 54-55 °C154. 
1H NMR (300 MHz, CDCl3): δH (ppm): 7.97 (s, 1H, H-C=C), 7.46 (d, J = 8.1 Hz, 2H, Ar-H), 
7.17 (d, J = 8.0 Hz, 2H, Ar-H), 2.37 (s, 3H, C-H), 2.31 (s, 3H, C-H, Z).  
13C NMR (75 MHz, CDCl3): δC (ppm): 146.5 (C=C, β carbon), 140.9 (C=C-CH3, carbon in 
the ring), 133.8 (C=C, α carbon), 130.2 (Ar), 129.7 (Ar), 129.5 (Ar), 21.3 (CH3, methyl 
carbon connected to the ring ), 14.1 (CH3, connectedβ carbon)  
GC/MS m/z (M+) 177. 
 
3.4.6 Synthesis of 3-nitrochromene derivatives 
3-Nitrochromene [54a]  
 
O
NO2CHO
OH
NO2 DABCO
54a
+
1a
40oC, 1.5 hrs
 
The synthesis method was based on that of Yan et al.187 A mixture of compound 1a (0.5g, 
3.4mmol) and salicylaldehyde (4.1g, 33.6mmol,) was swirled until the solution became 
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homogeneous, then a catalytic amount of DABCO (0.38g, 3.4mmol) was added to the 
mixed solution. The mixture was refluxed (under 40°C) for 1.5 hours and then 20mL of 5% 
hydrochloric acid (HCl) was added to the solution. Organic material was extracted using 
dichloromethane (3 x 60mL) and then dried over MgSO4, and filtered. Dichloromethane 
was removed under high vacuum. Purification of the compound was done by silica gel 
flash coloumn chromatography (ethyl acetate: hexane = 1: 50). A yellow-orange solid was 
obtained in yield of 43% and which had a melting point of 88-90°C (Lit. 88-89°C)187. 1H 
NMR and 13C NMR spectra are consistent with Yan et al. GC/MS m/z (M+) 253. 
 
3-Nitrochromene with para substitution of fluorine on phenyl ring [54b] 
O
NO2
F54b  
A similar procedure was used to obtain compound 54b. The quantities of chemicals used 
were: compound 1b (0.23g, 1.4mmol), salicylaldehyde (1.68g, 13.8mmol) and DABCO 
(0.15g, 1.4mmol). The reaction was carried out under the same reaction conditions and 
the purification was as for 54a. A yellow solid was obtained in yield of 55% and which had 
melting a point of 88-89°C.  
1H NMR (300 MHz, CDCl3): δH (ppm): 7.98 (s, 1H, C=αC-H), 7.30-7.24 (m, due to peaks 
are overlapping each other, 4H, Ar-H), 6.96-6.89 (due to peaks are overlapping each 
other, 3H, Ar-H), 6.80-6.77 (d, J = 8.4 Hz, 1H, Ar-H), 6.47 (s, 1H, O-C-H).  
13C NMR (75 MHz, CDCl3): δC (ppm): 164.9-161.6 (d, J = 249.1 Hz, 1C, Ar-C-F), 153.3 
(Ar), 141.0 (s, C=C=NO2), 134.4 (s, 2C, Ar-C), 132.7 (s, 1C, C-Ar-F), 130.4 (Ar), 129.3 
(Ar), 129.0 (Ar), 122.6 (Ar), 117.8 (C=C-C in between of two Ar), 117.3 (Ar), 115.8 (Ar), 
73.5 (s, 1C, O-C-Ar-F).  
GC/MS m/z (M+) 271. 
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3.4.7 Synthesis of β-ethyl- β-nitrostyrene 
2-Nitrobut-1-enyl- benzene [55] 
NO2CHO NO2
CH3COONH4
55Reflux  
The method of Kawai et al.188 was used. A mixture of benzaldehyde (2.12g, 20mmol), 
ammonium acetate (1.54g, 20mmol) and 1-nitropropane (39.9g, 448.5mmol) was refluxed 
at 110°C overnight (18 hours). The excess 1-nitropropane was removed under high 
vacuum and after addition of water (30mL), the organic materials were extracted with ethyl 
acetate (3 x 30mL) and the extract then dried over MgSO4. The combined extracts were 
filtered and concentrated under high vacuum. The product was purified by silica gel 
column chromatography with hexane/ethyl acetate (20: 1) to obtain a yellow liquid [55] in 
yield of 60%.  
1H NMR (300 MHz, CDCl3): δH (ppm): 8.03 (s, 1H, C=C-H), 7.47-7.45 (m, 5H, Ar-H), 2.92-
2.85 (q, J = 7.5 Hz, 2H, CH2), 1.32-1.27 (t, J = 7.5 Hz, 3H, CH3)188.  
13C NMR (75 MHz, CDCl3): δC (ppm): 153.3 (s, C=C, β carbon), 133.1 (s, C=C, α carbon), 
132.3, (Ar), 129.9 (Ar), 129.6 (2C, Ar), 129.0 (2C, Ar), 20.7 (s, CH2), 12.5 (s, CH3).  
GC/MS m/z (M+) 177. 
 
3.4.8 Synthesis of nitro-naphthalene derivatives 
1-(Nitroprop-2-enyl) naphthalene [53a] 
NO2
53a  
Method B was applied for this reaction and likewise for compound 53b. A mixture of 1-
naphthaldehyde (1g, 6.4mmol), ammonium acetate (0.99g, 12.8mmol) and glacial acetic 
acid (3mL) in nitroethane (0.6g, 8.0mmol) was refluxed for 2 hours in an oil bath at 100°C. 
The orange coloured mixture was then chilled and de-ionized water (6mL) was then 
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added to the orange mixture and the product which precipitated was then recrystallized 
from 95% ethanol. After washing with cold 95% ethanol a light yellow solid, 53a, was 
obtained in yield 49% and which had a melting point of 62-64°C189.  
1H NMR (300 MHz, CDCl3): δH (ppm): Due to multiplets occurred in the spectra because 
of the protons in both aromatic ring overlapped to each other, the integration of the proton 
will be used to identify the peaks.8.62 (Integration of 1H: 1, αC-H), 7.98-7.87 (Integration 
of 1H: 3, Ar-H), 7.64-7.51 (Integration of 1H: 4, Ar-H), 2.39 (Integration of 1H: 3, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 149.3 135.7 (s, C=C, β carbon), 133.5 (Ar), 131.9 
(Ar), 131.4 (s, C in between two rings), 130.2 (s, C=C, α carbon), 129.7 (s, C in between 
two rings), 128.8 (Ar), 127.1 (s, 2C, Ar), 126.6 (Ar), 125.1 (Ar), 124.1 (Ar), 14.1 (s, 1C, 
CH3).  
GC/MS m/z (M+) 213. 
 
2-(Nitroprop-2-enyl) naphthalene [53b] 
53b
NO2
 
Quantities of chemicals used were: 2-naphthaldehyde (0.5g, 3.2mmol), nitroethane (0.3g, 
4.0mmol), ammonium acetate (0.49g, 6.4mmol) and glacial acetic acid (3mL). An orange-
yellow solid was obtained in yield of 41% and melting point 90-91°C190.  
1H NMR (300 MHz, CDCl3): δH (ppm): Same as 53a, the integration of the proton will be 
used to identify the peaks. 8.20 (Integration of 1H: 1, αC-H), 7.88-7.79 (Integration of 1H: 4, 
Ar-H), 7.49-7.43 (Integration of 1H: 3, Ar-H), 2.79 (Integration of 1H: 3, CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 147.8 (s, C=C, β carbon), 133.7 (Ar), 133.5 (Ar), 
133.0 (s, C in between two rings), 130.5 (s, C=C, α carbon), 129.8 (s, C in between two 
rings), 128.6 (Ar), 128.4 (Ar), 127.7 (Ar), 127.6 (Ar), 126.9 (Ar), 126.3 (Ar), 14.2 (s,1C, 
CH3).  
GC/MS m/z (M+) 213. 
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3.4.9 Materials to synthesize the novel compound 
2,4-Dimethoxy- β-nitrostyrene [1c] 
OCH3
H3CO
NO2
1c  
The method to make this compound was based on Fierro et al.191 and also for the other 
dinitro compound [56b]. A mixture of 2,4-dimethoxybenzaldehyde (20g, 120.4mmol), n-
butylamine (12.1 mL) and glacial acetic acid (120 mL) in nitromethane (14.7g, 240.8mmol) 
was refluxed for 1.5 hours at 110°C. The dark brown mixture was evaporated by high 
vacuum to remove the acid and water (more than 20 mL) was added to the neutralized 
mixture which became a yellow colour. Compound 1c was then filtered and recrystallized 
in methanol to form yellow solids obtained in yield 64% and melting point of 101-104°C192.  
1H NMR (300 MHz, CDCl3): δH (ppm): 8.10-8.06 (d, J = 13.5 Hz, 1H, C=αC-H), 7.85-7.80 
(d, J = 13.5 Hz, 1H, C=βC-H), 7.39-7.37 (d, J = 8.4 Hz, 1H, Ar-H), 6.57-6.54 (d, J = 8.6 Hz, 
1H, Ar-H), 6.49 (s, 1H, Ar-H), 3.93 (s, 6H, O-CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 164.2 (s, 4-C-O in Ar), 161.2 (s, 2-C-O in Ar), 136.0 
(s, C=C, α carbon), 135.7 (s, C=C, β carbon), 134.3 (Ar), 112.4 (Ar), 105.9 (Ar), 98.6 (Ar), 
55.6 (s, CH3).  
GC/MS m/z (M+) 209. 
 
2-[2 ,´4 -´Dimethoxybenzene]-1,3-dinitropropanes [56b] 
OCH3
H3CO
NO2
NO2
56b  
The method to synthesize this compound was also based on Fierro et al.191, the starting 
material 1c (9g, 43mmol) and a base, potassium fluoride (3.2538g, 51.6mmol) were 
added in nitromethane (5340mmol) and refluxed with stirring at 110°C for 1.5 hours. The 
orange brown mixture was then evaporated under high vacuum to remove the excess 
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nitromethane and the solid dissolved in ethyl acetate (100 mL). After washing with water 
(50 mL) and then with diethyl ether (2 x 50 mL). The combined organic extract was 
washed again with water (3 x 40 mL). The organic extract was dried over MgSO4 the 
diethyl ether was removed under high vacuum to obtain a light brown solid in yield 88% 
with melting point of 53-56°C.  
1H NMR (300 MHz, CDCl3): δH (ppm): 7.06-7.02 (d, J = 8.1 Hz, 1H, C=C-H the ortho 
hydrogen in the ring), 6.49-6.41(broad peaks due to chemical shifting and coupling of the 
para proton and ortho hydrogen and little coupling occurred with meta hydrogen in the 
ring), 4.84-4.82 (d, J = 6.90 Hz, 4H, H-H-C next to NO2), 4.42-4.34 (p, J = 14.1, 7.2, 6.9 
Hz, C=C-C-H), 3.87-3.79 (s, 6H, O-CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 161.4 (s, 1C, C-OCH3), 158.1 (s, 1C, C-OCH3), 
130.6 (Ar), 114.2 (Ar), 104.8 (Ar), 99.3 (Ar), 75.6 (s, 2C, CH2), 55.5 (s, 1C, OCH3), 55.4 (s, 
1C, OCH3), 38.9 (s, 1C, NO2-C-C-C-NO2).  
GC/MS m/z (M+) 270. 
 
3.5 Attempted synthesis of other nitro compounds 
There were a few additional compounds required to be made for antimicrobial tests [56a, 
57, 58a and 58b] and also as starting materials [59 and 60] required for making novel 
compounds. All of them, except 57, are mentioned in the literature, but none were able to 
be synthesized successfully. They are described below: 
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3.5.1 Compound with fluorine substitution on α-carbon 
α-Fluoro-β-methyl-β-nitrostyrene [57] 
F
NO2
57  
The synthesis procedure was based on Yusubov et al.193. To a mixture of solution of 1-
phenyl-1-propyne (0.7g, 6.0mmol) and sodium nitrate (1.02g, 12.0mmol) in acetic acid 
(20mL), potassium fluoride (0.35g, 6.0mmol) was added when the solution was at 85°C. 
The orange mixture was refluxed overnight (18 hours) and the product formation was 
monitored by TLC. The reaction mixture was then poured into water (60mL) and extracted 
with diethyl ether (3 x 100mL). The organic extracts were washed with water (3 x100mL) 
and saturated brine solution (25%. 60mL) and dried over MgSO4. Diethyl ether was 
removed by high vacuum. However, the orange coloured compound with some white 
crystals was still not pure and it could not be purified by column chromatography. 
 
3.5.2 Compounds mentioned in literature 
(4-Nitrobuta-1,3-dienyl)benzene [58a] 
NO2CHO CH3NO2
58a
MeOH, NaOH, -10
o
C
 
Attempts were made to synthesize this compound using Method A, Method B and a 
literature method from Dockendorff et al.194, but none of them was successful.  
 
(4-Nitropenta-1,3-dienyl)benzene [58b] 
NO2
58b  
Methods A, B and the method from Dockendorff et al.194 were used for this compound. 
Neither of them succeeded as well as described. However, method from RodrÃguez and 
Dolors Pujol195 suggested another possibility to synthesize 58a and 58b. 
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(1,3-Dinitroprop-2-enyl)benzene [56a] 
NO2
NO2
CHO
CH3NO2
NO2
OH
NO2-CH2NO2
56a
+
1a
78%
 
Attempts were made to synthesize this compound using the methods from Ballini et al.196 
and Iturriaga-Vásquez et al.197. However neither method yielded the dinitro-compound. 
The method of Fierro et al.191 to make compound 56b may be the way to synthesize this 
compound 
 
3.5.3 Attempted synthesis of starting materials 
3,3,3-Trifluoro-1-phenylpropyne [59] 
CF3
59  
The literature method was according to Bunch and Bumgardner198. However, due to 
limited material available for the reaction, the compound could not be obtained. 
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Alkyl Phosphonate [60] 
NO2
PC2H5O
OH5C2
O
O2N
-
PC2H5O
OH5C2
O
O2N
1. 2LDA/THF, -78oC
2. (C2H5O)3POCl/THF
-78oC --> -30oC
H2O or
CH3COOH/THF, -78
oC
47 - 75%
60  
The method of synthesis was from Kandil et al.199 on a 50% scale. A solution of lithium 
diisopropylamide (LDA, 1.6mL, 11mmol diisopropylamine reacted with 1.0mL, 11mmol of 
2.5M n-butyllithium in hexane) in dry tetrahydrofuran (THF, 25mL) was prepared under 
nitrogen at -78°C. Nitroethane (0.412g, 5.5mmol) in dry THF (50mL) was then added 
dropwise over half an hour. The mixture was stirred for another half hour and a solution of 
diethyl chlorophosphate (0.95g, 5.5mmol) in dry THF (5mL) was added dropwise over 15 
minutes and the mixture was stirred continuously for an additional 3 hours. The solution 
was warmed to -30°C and stirred for another 2 hours. After that the mixture was cooled 
back to -78°C and acetic acid (1.32g, 22mmol) in dry THF was added dropwise to quench 
the mixture and stirring was maintained for one hour at -78°C. The mixture was then 
gradually warmed to room temperature. The mixture was diluted with water (50mL) and 
the organic materials were extracted with ethyl acetate (3 x 25mL), washed with saturated 
brine solution (25%, 2 x 14mL) and dried with MgSO4. The combined extracts were filtered 
and concentrated under high vacuum. Further purifications were achieved by dissolving 
the compound in ether (20mL) and then extracting with the saturated sodium carbonate 
solution (3 x 20mL). The combined aqueous extracts were washed with diethyl ether (2 x 
20mL) and acidified to pH 7 by glacial acetic acid and to pH 2 with 10% aqueous 
hydrochloric acid. The remaining compound was then extracted with diethyl ether (3 x 
50mL), filtered and dried over MgSO4. The solvent was removed in high vacuum, but the 
desired product could not be obtained, which was shown by 1H NMR and GC/MS.  
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3.5.4 Other compounds synthesized by Professor Hugh Cornell 
1,2-Dimethoxy-4-(2-nitroprop-1-enyl)benzene [9b] 
Na2CO3, CH2NH2.HCl
KOH in ethanol, EtOH
H3CO
H3CO
CHO
NO2+
Room temperature
H3CO
H3CO
NO2
9b  
Compound 9b was prepared by Method A. A mixture of 3,4-dimethoxybenzaldehyde 
(1.66g, 10mmol), nitroethane (1g, 13.3mmol), anhydrous sodium carbonate (0.2g, 2mmol), 
methylamine hydrochloride (0.11g, 1.5mmol) potassium hydroxide (0.05g, 0.9mmol, 
dissolved in 1.0 mL ethanol) and ethanol (2.5mL) was reacted at room temperature with 
sufficient stirring for 24 hours. After that, the mixture was diluted with water (3mL) and 
chilled to 5°C for 3 hours. The crude product was filtered and air dried, recrystallized with 
95% ethanol and air dried. The final product was yellow and crystalline with yield of 27% 
and a melting point of 71-72°C22.  
1H NMR (300 MHz, CDCl3): δH (ppm): 7.99 (s, 1H, C=C-H), 6.94 (s, 1H, Ar-H), 7.03-7.00 
(d, J = 8.1 Hz, 1H, Ar-H), 6.88-6.85 (d, J = 9.3 Hz, 1H, Ar-H), 3.85 (s, 6H, OCH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 150.7 (s, C3 of C-OCH3 in the ring), 149.1 (s, C4 of 
C-OCH3 in the ring), 145.9 (s, C=C, β carbon), 133.8 (Ar), 125.0 (s, C=C, α carbon), 124.0 
(Ar), 113.0 (Ar), 111.2 (Ar), 56.0 (s, 2C, OCH3), 14.1 (CH3).  
GC/MS m/z (M+) 223. 
 
1-Hydroxy-4-(2-nitroprop-1-enyl)benzene [8b] 
HO
CHO
+ NO2
Na2CO3, CH2NH2.HCl
KOH in ethanol, EtOH
Room temperature
HO
NO2
8b  
Method A was also used for preparation 8b. A mixture of 4-hydroxybenzaldehyde (2.44g, 
20mmol) dissolved in absolute ethanol (3mL), nitroethane (2g, 26.6mmol), anhydrous 
sodium carbonate (0.3g, 3mmol) and methylamine hydrochloride (0.15g, 2.2mmol), was 
prepared and a solution of potassium hydroxide (0.05g, 0.9mmol, dissolved in 1.0 mL 
ethanol) added with thorough mixing. The mixture was reacted at room temperature with 
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sufficient stirring for 48 hours. Yellow crystals were obtained after chilling to 5°C for 2 
hours. The crude product was filtered and recrystallized from 95% ethanol to yield 1g of 
product (50% of the theoretical yield) and melting point 121-122°C200.  
1H NMR (300 MHz, DMSO): δH (ppm): 8.03 (s, 1H, C=C-H), 7.50-7.47 (d, J = 8.7 Hz, 1H, 
Ar-H), 6.90-6.87 (d, 8.7 Hz, 1H, Ar-H), 2.40 (s, 3H, CH3).  
13C NMR (75 MHz, DMSO): δC (ppm): 159.7 (s, C-OH), 144.4 (s, C=C, α carbon), 133.7 
(s, C=C, β carbon), 132.8 (Ar), 122.5 (Ar), 115.9 (Ar), 13.9 (CH3).  
GC/MS m/z (M+) 179. 
 
1,4-Bis-(2-nitro-propenyl)-benzene [51] 
NO2
CH3COONH4, CH3COOH
Reflux
NO2O2NOHC CHO
51  
Method B was applied to produce this compound. A stirred mixture of 
terephthaldicarboxaldehyde (1.34g, 10mmol), nitroethane (1.8g, 24mmol) and ammonium 
acetate (2g, 26mmol) in glacial acetic acid (3mL) was refluxed for 1 hour in an oil bath at 
100°C. A yellow precipitate formed which was washed with water and extracted with ethyl 
acetate (2 x 15mL). The orange solution was dried over MgSO4 and then concentrated 
under high vacuum. A semi-solid was formed with melting point 90-95°C. The semi-solid 
was then recrystallized with ethanol (95%) and produced a yellow solid in yield 18% with 
melting point 99-101°C201. The method from Fierro et al.191 is potentially another good 
method to synthesize this compound. 
1H NMR (300 MHz, CDCl3): δH (ppm): 8.10 (s, 2H, C=C-H), 7.54 (s, 4H, Ar-H), 2.50 (s, 6H, 
CH3).  
13C NMR (75 MHz, CDCl3): δC (ppm): 148.7 (s, C=C, β carbon), 133.8 (Ar), 132.4 (s, C=C, 
α carbon), 130.3 (s, 4C in Ar), 14.1 (s, 2C, CH3).  
GC/MS m/z (M+) 248 
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Appendix 
Compound no.: Name 
25: 4-fluorobut-2-ynyl 2-(3-fluoro-4-methylphenyl)-3,3-dimethylbutanoate 
26: 4-(2,3-difluorophenyl)-6-(4-fluorobut-2-ynyloxy)pyrimidine 
27: 3-(4-fluorobut-2-ynyloxy)-5-phenyl-1,2,4-thiadiazole 
28: 1-(4-(3-chlorophenyl)-4-fluorobut-2-ynyloxy)-4-fluoro-2-methoxybenzene 
29: 6-(4-chlorophenyl)-2-(4-fluoropent-2-ynyl)-4,5-dihydropyridazin-3(2H)-one 
30: methyl-2-chloro-5-(3-fluoro-3,4-dimethylpent-1-ynyl)benzylcarbamate 
31:(E)-methyl-3-methoxy-2-(2-methyl-5-(3,4,4,4-tetrafluoro-3-methylbut-1-
ynyl)phenoxy)acrylate 
32: 4′-(3-fluorobut-1-ynyl)biphenyl-2-amine 
33: methyl 2-(7-(3-fluoro-3-methylbut-1-ynyl)naphthalen-1-yl)-3-methoxypropanoate 
34: 2-((5-(3-fluorobut-1-ynyl)thiophen-2-yl)ethynyl)benzo[b]thiophene 
35: 6-chloro-4-cyclopropyl-4-(3-fluoroprop-1-ynyl)-3,4-dihydroquinazolin-2(1H)-one 
36:N-(4-chlorobenzyl)-8-(3-fluoroprop-1-ynyl)-1-methyl-6-(morpholinomethyl)-4-oxy1,4-
dihydroquinoline-3-carboxamide 
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Table of all structures with measured logP and calculated logP 
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